bcr_patient_barcode,type,age_at_initial_pathologic_diagnosis,gender,race,ajcc_pathologic_tumor_stage,clinical_stage,histological_type,histological_grade,initial_pathologic_dx_year,menopause_status,birth_days_to,vital_status,tumor_status,last_contact_days_to,death_days_to,cause_of_death,new_tumor_event_type,new_tumor_event_site,new_tumor_event_site_other,new_tumor_event_dx_days_to,treatment_outcome_first_course,margin_status,residual_tumor,OS,OS.time,DSS,DSS.time,DFI,DFI.time,PFI,PFI.time,Redaction
TCGA-3C-AAAU,BRCA,55,FEMALE,WHITE,Stage X,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20211,Alive,WITH TUMOR,4047,NA,[Not Available],Distant Metastasis,Lung,NA,1808,[Not Available],Negative,NA,0,4047,0,4047,1,1808,1,1808,
TCGA-3C-AALI,BRCA,50,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18538,Alive,TUMOR FREE,4005,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,4005,0,4005,0,4005,0,4005,
TCGA-3C-AALJ,BRCA,62,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22848,Alive,TUMOR FREE,1474,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1474,0,1474,0,1474,0,1474,
TCGA-3C-AALK,BRCA,52,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,[Unknown],-19074,Alive,TUMOR FREE,1448,NA,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,0,1448,0,1448,NA,NA,0,1448,
TCGA-4H-AAAK,BRCA,50,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18371,Alive,TUMOR FREE,348,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,348,0,348,0,348,0,348,
TCGA-5L-AAT0,BRCA,42,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-15393,Alive,TUMOR FREE,1477,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,1477,0,1477,NA,NA,0,1477,
TCGA-5L-AAT1,BRCA,63,FEMALE,WHITE,Stage IV,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23225,Alive,WITH TUMOR,1471,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1471,0,1471,NA,NA,0,1471,
TCGA-5T-A9QA,BRCA,52,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2013,[Unknown],-19031,Alive,NA,303,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Unknown],NA,0,303,0,303,NA,NA,0,303,
TCGA-A1-A0SB,BRCA,70,FEMALE,WHITE,Stage I,[Not Applicable],"Other, specify",[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25833,Alive,TUMOR FREE,259,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,259,0,259,0,259,0,259,
TCGA-A1-A0SD,BRCA,59,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,[Not Available],-21793,Alive,NA,437,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,437,0,437,0,437,0,437,
TCGA-A1-A0SE,BRCA,56,FEMALE,WHITE,Stage I,[Not Applicable],Mixed Histology (please specify),[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20717,Alive,TUMOR FREE,1321,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1321,0,1321,0,1321,0,1321,
TCGA-A1-A0SF,BRCA,54,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19731,Alive,TUMOR FREE,1463,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1463,0,1463,0,1463,0,1463,
TCGA-A1-A0SG,BRCA,61,FEMALE,WHITE,Stage IIB,[Not Applicable],"Other, specify",[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22380,Alive,NA,434,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,434,0,434,0,434,0,434,
TCGA-A1-A0SH,BRCA,39,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14595,Alive,TUMOR FREE,1437,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1437,0,1437,0,1437,0,1437,
TCGA-A1-A0SI,BRCA,52,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,[Not Available],-19250,Alive,TUMOR FREE,635,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,635,0,635,0,635,0,635,
TCGA-A1-A0SJ,BRCA,39,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,[Not Available],-14383,Alive,TUMOR FREE,416,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,416,0,416,0,416,0,416,
TCGA-A1-A0SK,BRCA,54,FEMALE,ASIAN,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2007,Indeterminate (neither Pre or Postmenopausal),-20048,Dead,WITH TUMOR,NA,967,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,967,1,967,NA,NA,1,967,
TCGA-A1-A0SM,BRCA,77,MALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,[Not Available],-28198,Alive,TUMOR FREE,242,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,242,0,242,0,242,0,242,
TCGA-A1-A0SN,BRCA,50,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18401,Alive,TUMOR FREE,1196,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1196,0,1196,0,1196,0,1196,
TCGA-A1-A0SO,BRCA,67,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24826,Alive,TUMOR FREE,852,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,852,0,852,0,852,0,852,
TCGA-A1-A0SP,BRCA,40,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,[Not Available],-14954,Alive,TUMOR FREE,584,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,584,0,584,0,584,0,584,
TCGA-A1-A0SQ,BRCA,45,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16458,Alive,TUMOR FREE,554,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,554,0,554,0,554,0,554,
TCGA-A2-A04N,BRCA,66,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24155,Alive,TUMOR FREE,4354,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,4354,0,4354,0,4354,0,4354,
TCGA-A2-A04P,BRCA,36,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13238,Dead,WITH TUMOR,NA,548,[Not Available],Distant Metastasis,Bone,NA,102,[Not Available],Positive,NA,1,548,1,548,NA,NA,1,102,
TCGA-A2-A04Q,BRCA,48,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17660,Alive,TUMOR FREE,2385,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2385,0,2385,0,2385,0,2385,
TCGA-A2-A04R,BRCA,36,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13483,Alive,TUMOR FREE,3709,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3709,0,3709,0,3709,0,3709,
TCGA-A2-A04T,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22707,Alive,TUMOR FREE,2246,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2246,0,2246,0,2246,0,2246,
TCGA-A2-A04U,BRCA,47,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Peri (6-12 months since last menstrual period),-17474,Alive,TUMOR FREE,2654,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2654,0,2654,0,2654,0,2654,
TCGA-A2-A04V,BRCA,39,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14250,Dead,WITH TUMOR,NA,1920,[Not Available],NA,NA,NA,1470,[Not Available],Negative,NA,1,1920,1,1920,1,1470,1,1470,
TCGA-A2-A04W,BRCA,50,FEMALE,WHITE,Stage IIB,[Not Applicable],"Other, specify",[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18345,Alive,TUMOR FREE,3102,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3102,0,3102,0,3102,0,3102,
TCGA-A2-A04X,BRCA,34,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12642,Alive,TUMOR FREE,1686,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1686,0,1686,0,1686,0,1686,
TCGA-A2-A04Y,BRCA,53,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19533,Alive,TUMOR FREE,1099,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1099,0,1099,0,1099,0,1099,
TCGA-A2-A0CK,BRCA,60,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2001,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22094,Alive,TUMOR FREE,4159,NA,[Not Available],New Primary Tumor,"Other, specify",LEFT BREAST,1364,[Not Available],Negative,NA,0,4159,0,4159,1,1364,1,1364,
TCGA-A2-A0CL,BRCA,37,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13556,Alive,TUMOR FREE,3015,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,3015,0,3015,NA,NA,0,3015,
TCGA-A2-A0CM,BRCA,40,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14969,Dead,WITH TUMOR,NA,754,[Not Available],NA,NA,NA,382,[Not Available],Negative,NA,1,754,1,754,1,382,1,382,
TCGA-A2-A0CO,BRCA,85,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31404,Dead,TUMOR FREE,NA,3492,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,1,3492,0,3492,NA,NA,0,3492,
TCGA-A2-A0CP,BRCA,60,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22133,Alive,TUMOR FREE,2813,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2813,0,2813,0,2813,0,2813,
TCGA-A2-A0CQ,BRCA,62,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22810,Alive,TUMOR FREE,2695,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2695,0,2695,0,2695,0,2695,
TCGA-A2-A0CR,BRCA,54,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20075,Alive,TUMOR FREE,3283,NA,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,0,3283,0,3283,NA,NA,0,3283,
TCGA-A2-A0CS,BRCA,73,FEMALE,WHITE,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26817,Dead,TUMOR FREE,NA,2348,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,1,2348,0,2348,NA,NA,0,2348,
TCGA-A2-A0CT,BRCA,71,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25959,Alive,TUMOR FREE,2289,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2289,0,2289,0,2289,0,2289,
TCGA-A2-A0CU,BRCA,73,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26823,Dead,TUMOR FREE,NA,158,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,1,158,0,158,NA,NA,0,158,
TCGA-A2-A0CV,BRCA,41,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-15289,Alive,TUMOR FREE,3011,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3011,0,3011,0,3011,0,3011,
TCGA-A2-A0CW,BRCA,67,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24541,Alive,TUMOR FREE,3283,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3283,0,3283,0,3283,0,3283,
TCGA-A2-A0CX,BRCA,52,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19152,Alive,TUMOR FREE,1728,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1728,0,1728,0,1728,0,1728,
TCGA-A2-A0CY,BRCA,63,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23229,Alive,TUMOR FREE,1673,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1673,0,1673,0,1673,0,1673,
TCGA-A2-A0CZ,BRCA,46,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Peri (6-12 months since last menstrual period),-17026,Alive,TUMOR FREE,1616,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,1616,0,1616,NA,NA,0,1616,
TCGA-A2-A0D0,BRCA,60,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22115,Alive,TUMOR FREE,2048,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2048,0,2048,0,2048,0,2048,
TCGA-A2-A0D1,BRCA,76,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28084,Alive,TUMOR FREE,1051,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1051,0,1051,0,1051,0,1051,
TCGA-A2-A0D2,BRCA,45,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16623,Alive,TUMOR FREE,1027,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1027,0,1027,0,1027,0,1027,
TCGA-A2-A0D3,BRCA,42,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-15524,Alive,TUMOR FREE,1873,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1873,0,1873,0,1873,0,1873,
TCGA-A2-A0D4,BRCA,37,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13805,Alive,TUMOR FREE,767,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,767,0,767,0,767,0,767,
TCGA-A2-A0EM,BRCA,73,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26845,Alive,TUMOR FREE,3094,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3094,0,3094,0,3094,0,3094,
TCGA-A2-A0EN,BRCA,70,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25771,Alive,TUMOR FREE,4088,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,4088,0,4088,0,4088,0,4088,
TCGA-A2-A0EO,BRCA,54,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Peri (6-12 months since last menstrual period),-19880,Alive,TUMOR FREE,2442,NA,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,0,2442,0,2442,NA,NA,0,2442,
TCGA-A2-A0EP,BRCA,56,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20585,Alive,TUMOR FREE,3603,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3603,0,3603,0,3603,0,3603,
TCGA-A2-A0EQ,BRCA,64,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23543,Alive,TUMOR FREE,2426,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2426,0,2426,0,2426,0,2426,
TCGA-A2-A0ER,BRCA,63,FEMALE,WHITE,Stage IB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23021,Alive,TUMOR FREE,2263,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2263,0,2263,0,2263,0,2263,
TCGA-A2-A0ES,BRCA,52,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19160,Alive,TUMOR FREE,2190,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2190,0,2190,0,2190,0,2190,
TCGA-A2-A0ET,BRCA,58,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21464,Alive,TUMOR FREE,1066,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1066,0,1066,0,1066,0,1066,
TCGA-A2-A0EU,BRCA,79,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29144,Alive,TUMOR FREE,1043,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1043,0,1043,0,1043,0,1043,
TCGA-A2-A0EV,BRCA,80,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29285,Alive,TUMOR FREE,968,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,968,0,968,0,968,0,968,
TCGA-A2-A0EW,BRCA,53,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19413,Dead,WITH TUMOR,NA,1884,[Not Available],Distant Metastasis,Bone,NA,1353,[Not Available],Positive,NA,1,1884,1,1884,NA,NA,1,1353,
TCGA-A2-A0EX,BRCA,46,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16858,Alive,TUMOR FREE,752,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,752,0,752,0,752,0,752,
TCGA-A2-A0EY,BRCA,62,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22872,Alive,TUMOR FREE,1925,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1925,0,1925,0,1925,0,1925,
TCGA-A2-A0ST,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22922,Alive,WITH TUMOR,3017,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3017,0,3017,0,3017,0,3017,
TCGA-A2-A0SU,BRCA,66,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24219,Alive,TUMOR FREE,1662,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1662,0,1662,0,1662,0,1662,
TCGA-A2-A0SV,BRCA,63,FEMALE,WHITE,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23126,Dead,WITH TUMOR,NA,825,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,1,825,1,825,NA,NA,1,825,
TCGA-A2-A0SW,BRCA,82,FEMALE,WHITE,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30085,Dead,WITH TUMOR,NA,1365,[Not Available],NA,NA,NA,653,[Not Available],Negative,NA,1,1365,1,1365,NA,NA,1,653,
TCGA-A2-A0SX,BRCA,48,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17774,Alive,WITH TUMOR,1534,NA,[Not Available],NA,NA,NA,1239,[Not Available],Negative,NA,0,1534,0,1534,1,1239,1,1239,
TCGA-A2-A0SY,BRCA,62,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22928,Alive,TUMOR FREE,1347,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1347,0,1347,0,1347,0,1347,
TCGA-A2-A0T0,BRCA,59,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21575,Alive,TUMOR FREE,533,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,533,0,533,0,533,0,533,
TCGA-A2-A0T1,BRCA,55,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20227,Alive,TUMOR FREE,521,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,521,0,521,0,521,0,521,
TCGA-A2-A0T2,BRCA,66,FEMALE,WHITE,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24235,Dead,WITH TUMOR,NA,255,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,1,255,1,255,NA,NA,1,255,
TCGA-A2-A0T3,BRCA,37,FEMALE,WHITE,Stage IB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13680,Alive,TUMOR FREE,1516,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1516,0,1516,0,1516,0,1516,
TCGA-A2-A0T4,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22849,Alive,TUMOR FREE,624,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,624,0,624,0,624,0,624,
TCGA-A2-A0T5,BRCA,39,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14503,Alive,TUMOR FREE,531,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,531,0,531,0,531,0,531,
TCGA-A2-A0T6,BRCA,50,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18334,Alive,TUMOR FREE,575,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,575,0,575,0,575,0,575,
TCGA-A2-A0T7,BRCA,51,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18756,Alive,TUMOR FREE,631,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,631,0,631,0,631,0,631,
TCGA-A2-A0YC,BRCA,59,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21685,Alive,WITH TUMOR,990,NA,[Not Available],Locoregional Disease,NA,NA,756,[Not Available],Close,NA,0,990,0,990,NA,NA,1,756,
TCGA-A2-A0YD,BRCA,63,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23021,Alive,TUMOR FREE,769,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,769,0,769,0,769,0,769,
TCGA-A2-A0YE,BRCA,48,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17727,Alive,TUMOR FREE,554,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,554,0,554,0,554,0,554,
TCGA-A2-A0YF,BRCA,67,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24660,Alive,TUMOR FREE,1535,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1535,0,1535,0,1535,0,1535,
TCGA-A2-A0YG,BRCA,63,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23058,Alive,TUMOR FREE,666,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,666,0,666,0,666,0,666,
TCGA-A2-A0YH,BRCA,53,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19596,Alive,TUMOR FREE,659,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,659,0,659,0,659,0,659,
TCGA-A2-A0YI,BRCA,62,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22961,Alive,TUMOR FREE,1505,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1505,0,1505,0,1505,0,1505,
TCGA-A2-A0YJ,BRCA,39,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14448,Alive,WITH TUMOR,566,NA,[Not Available],Distant Metastasis,"Other, specify",Left Cervical Lymph Node,559,[Not Available],Negative,NA,0,566,0,566,1,559,1,559,
TCGA-A2-A0YK,BRCA,61,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22625,Alive,TUMOR FREE,588,NA,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,0,588,0,588,NA,NA,0,588,
TCGA-A2-A0YL,BRCA,48,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17702,Alive,TUMOR FREE,1474,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1474,0,1474,0,1474,0,1474,
TCGA-A2-A0YM,BRCA,67,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24831,Alive,TUMOR FREE,965,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,965,0,965,0,965,0,965,
TCGA-A2-A0YT,BRCA,56,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20482,Dead,TUMOR FREE,NA,723,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,723,0,723,0,723,0,723,
TCGA-A2-A1FV,BRCA,74,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27287,Alive,TUMOR FREE,714,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,714,0,714,0,714,0,714,
TCGA-A2-A1FW,BRCA,62,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22779,Alive,TUMOR FREE,528,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,528,0,528,0,528,0,528,
TCGA-A2-A1FX,BRCA,61,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22344,Alive,TUMOR FREE,1847,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1847,0,1847,0,1847,0,1847,
TCGA-A2-A1FZ,BRCA,63,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23055,Alive,TUMOR FREE,683,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,683,0,683,0,683,0,683,
TCGA-A2-A1G0,BRCA,49,FEMALE,WHITE,Stage IIB,[Not Applicable],"Other, specify",[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18002,Alive,TUMOR FREE,616,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,616,0,616,0,616,0,616,
TCGA-A2-A1G1,BRCA,85,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31223,Alive,TUMOR FREE,584,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,584,0,584,0,584,0,584,
TCGA-A2-A1G4,BRCA,71,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25966,Alive,TUMOR FREE,595,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,595,0,595,0,595,0,595,
TCGA-A2-A1G6,BRCA,50,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18514,Alive,TUMOR FREE,501,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,501,0,501,0,501,0,501,
TCGA-A2-A259,BRCA,70,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25666,Alive,TUMOR FREE,1596,NA,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,0,1596,0,1596,NA,NA,0,1596,
TCGA-A2-A25A,BRCA,44,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2003,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16084,Alive,TUMOR FREE,3276,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3276,0,3276,0,3276,0,3276,
TCGA-A2-A25B,BRCA,39,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14454,Alive,WITH TUMOR,1291,NA,[Not Available],Distant Metastasis,Bone,NA,1290,[Not Available],Close,NA,0,1291,0,1291,NA,NA,1,1290,
TCGA-A2-A25C,BRCA,50,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18508,Alive,TUMOR FREE,523,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,523,0,523,0,523,0,523,
TCGA-A2-A25D,BRCA,90,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872,Alive,TUMOR FREE,552,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,552,0,552,NA,NA,0,552,
TCGA-A2-A25E,BRCA,34,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12601,Alive,TUMOR FREE,3204,NA,[Not Available],Locoregional Recurrence,"Other, specify",Left Chest Wall,2989,[Not Available],Negative,NA,0,3204,0,3204,1,2989,1,2989,
TCGA-A2-A25F,BRCA,66,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24319,Alive,TUMOR FREE,322,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,322,0,322,0,322,0,322,
TCGA-A2-A3KC,BRCA,55,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20401,Alive,TUMOR FREE,1102,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1102,0,1102,0,1102,0,1102,
TCGA-A2-A3KD,BRCA,47,FEMALE,WHITE,Stage IIIA,[Not Applicable],Mucinous Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17372,Alive,TUMOR FREE,1206,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,1206,0,1206,NA,NA,0,1206,
TCGA-A2-A3XS,BRCA,62,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23000,Dead,WITH TUMOR,NA,1032,[Not Available],Distant Metastasis,Lung,NA,682,[Not Available],Negative,NA,1,1032,1,1032,1,682,1,682,
TCGA-A2-A3XT,BRCA,45,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16649,Alive,TUMOR FREE,2770,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2770,0,2770,0,2770,0,2770,
TCGA-A2-A3XU,BRCA,35,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-13046,Dead,WITH TUMOR,NA,912,[Not Available],Distant Metastasis,Bone,NA,574,[Not Available],Negative,NA,1,912,1,912,1,574,1,574,
TCGA-A2-A3XV,BRCA,46,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16971,Alive,TUMOR FREE,996,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,996,0,996,0,996,0,996,
TCGA-A2-A3XW,BRCA,42,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15670,Alive,TUMOR FREE,1712,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1712,0,1712,0,1712,0,1712,
TCGA-A2-A3XX,BRCA,49,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17981,Dead,TUMOR FREE,NA,1439,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,1439,0,1439,0,1439,0,1439,
TCGA-A2-A3XY,BRCA,49,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18059,Dead,WITH TUMOR,NA,1093,[Not Available],Distant Metastasis,Lung,NA,802,[Not Available],Negative,NA,1,1093,1,1093,1,802,1,802,
TCGA-A2-A3XZ,BRCA,46,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16978,Alive,TUMOR FREE,1532,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1532,0,1532,0,1532,0,1532,
TCGA-A2-A3Y0,BRCA,57,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21024,Alive,TUMOR FREE,1546,NA,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,0,1546,0,1546,NA,NA,0,1546,
TCGA-A2-A4RW,BRCA,49,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18060,Alive,TUMOR FREE,222,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,222,0,222,0,222,0,222,
TCGA-A2-A4RX,BRCA,67,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Metaplastic Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24779,Alive,TUMOR FREE,742,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,742,0,742,0,742,0,742,
TCGA-A2-A4RY,BRCA,46,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17157,Alive,TUMOR FREE,648,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,648,0,648,0,648,0,648,
TCGA-A2-A4S0,BRCA,77,FEMALE,WHITE,Stage IIA,[Not Applicable],Mucinous Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28416,Alive,TUMOR FREE,706,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,706,0,706,0,706,0,706,
TCGA-A2-A4S1,BRCA,66,FEMALE,WHITE,Stage IIA,[Not Applicable],Metaplastic Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24353,Alive,TUMOR FREE,820,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,820,0,820,0,820,0,820,
TCGA-A2-A4S2,BRCA,62,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22936,Alive,TUMOR FREE,643,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,643,0,643,0,643,0,643,
TCGA-A2-A4S3,BRCA,59,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21762,Alive,TUMOR FREE,666,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,666,0,666,0,666,0,666,
TCGA-A7-A0CD,BRCA,66,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Indeterminate (neither Pre or Postmenopausal),-24242,Alive,TUMOR FREE,1165,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1165,0,1165,0,1165,0,1165,
TCGA-A7-A0CE,BRCA,57,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Indeterminate (neither Pre or Postmenopausal),-20863,Alive,TUMOR FREE,1074,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1074,0,1074,0,1074,0,1074,
TCGA-A7-A0CG,BRCA,78,FEMALE,WHITE,Stage IIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28596,Alive,TUMOR FREE,1043,NA,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,0,1043,0,1043,NA,NA,0,1043,
TCGA-A7-A0CH,BRCA,79,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29104,Alive,TUMOR FREE,1079,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1079,0,1079,0,1079,0,1079,
TCGA-A7-A0CJ,BRCA,57,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21014,Alive,TUMOR FREE,931,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,931,0,931,NA,NA,0,931,
TCGA-A7-A0D9,BRCA,37,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13836,Alive,TUMOR FREE,1139,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1139,0,1139,0,1139,0,1139,
TCGA-A7-A0DA,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22708,Alive,TUMOR FREE,1085,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1085,0,1085,0,1085,0,1085,
TCGA-A7-A0DB,BRCA,56,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20570,Alive,TUMOR FREE,1007,NA,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,0,1007,0,1007,NA,NA,0,1007,
TCGA-A7-A0DC,BRCA,63,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23294,Alive,TUMOR FREE,906,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,906,0,906,0,906,0,906,
TCGA-A7-A13D,BRCA,46,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17070,Alive,TUMOR FREE,965,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,965,0,965,0,965,0,965,
TCGA-A7-A13E,BRCA,62,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22690,Dead,WITH TUMOR,NA,614,[Not Available],Distant Metastasis,"Other, specify","Lung, Bone, Liver, Brain and Skin Nodules",556,[Not Available],Negative,NA,1,614,1,614,1,556,1,556,
TCGA-A7-A13F,BRCA,44,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16363,Alive,TUMOR FREE,765,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,765,0,765,0,765,0,765,
TCGA-A7-A13G,BRCA,79,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28969,Alive,TUMOR FREE,718,NA,[Not Available],New Primary Tumor,"Other, specify","Skin, right leg",586,[Not Available],Negative,NA,0,718,0,718,0,718,1,586,
TCGA-A7-A13H,BRCA,61,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22643,Alive,TUMOR FREE,899,NA,[Not Available],New Primary Tumor,"Other, specify",Skin lesion-Basal Cell Left Lower Lateral Back,795,[Not Available],Negative,NA,0,899,0,899,0,899,1,795,
TCGA-A7-A26E,BRCA,71,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26274,Alive,TUMOR FREE,954,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,954,0,954,0,954,0,954,
TCGA-A7-A26F,BRCA,55,FEMALE,WHITE,Stage IA,[Not Applicable],"Other, specify",[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20210,Alive,TUMOR FREE,738,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,738,0,738,0,738,0,738,
TCGA-A7-A26G,BRCA,50,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18362,Alive,TUMOR FREE,722,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,722,0,722,0,722,0,722,
TCGA-A7-A26H,BRCA,72,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26423,Alive,WITH TUMOR,724,NA,[Not Available],Distant Metastasis,Liver,NA,291,[Not Available],Negative,NA,0,724,0,724,1,291,1,291,
TCGA-A7-A26I,BRCA,65,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23948,Alive,TUMOR FREE,661,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,661,0,661,0,661,0,661,
TCGA-A7-A26J,BRCA,49,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17930,Alive,TUMOR FREE,627,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,627,0,627,0,627,0,627,
TCGA-A7-A2KD,BRCA,53,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19563,Alive,TUMOR FREE,679,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,679,0,679,0,679,0,679,
TCGA-A7-A3IY,BRCA,71,FEMALE,WHITE,Stage I,[Not Applicable],Mucinous Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26042,Alive,TUMOR FREE,345,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,345,0,345,0,345,0,345,
TCGA-A7-A3IZ,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22997,Alive,TUMOR FREE,322,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,322,0,322,0,322,0,322,
TCGA-A7-A3J0,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Mucinous Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22672,Alive,TUMOR FREE,313,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,313,0,313,0,313,0,313,
TCGA-A7-A3J1,BRCA,63,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23209,Alive,TUMOR FREE,343,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,343,0,343,0,343,0,343,
TCGA-A7-A3RF,BRCA,79,FEMALE,WHITE,Stage IIA,[Not Applicable],Mucinous Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29184,Alive,WITH TUMOR,408,NA,[Not Available],Distant Metastasis,Bone,NA,174,[Not Available],Negative,NA,0,408,0,408,1,174,1,174,
TCGA-A7-A425,BRCA,70,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25678,Alive,WITH TUMOR,447,NA,[Not Available],Locoregional Recurrence,"Other, specify",Left Breast,419,[Not Available],Negative,NA,0,447,0,447,1,419,1,419,
TCGA-A7-A426,BRCA,50,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18296,Alive,TUMOR FREE,364,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,364,0,364,0,364,0,364,
TCGA-A7-A4SA,BRCA,40,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14906,Alive,TUMOR FREE,454,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,454,0,454,0,454,0,454,
TCGA-A7-A4SB,BRCA,56,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20539,Alive,TUMOR FREE,418,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,418,0,418,0,418,0,418,
TCGA-A7-A4SC,BRCA,62,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23008,Alive,TUMOR FREE,446,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,446,0,446,0,446,0,446,
TCGA-A7-A4SD,BRCA,52,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19131,Alive,TUMOR FREE,441,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,441,0,441,0,441,0,441,
TCGA-A7-A4SE,BRCA,54,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20080,Alive,TUMOR FREE,644,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,644,0,644,0,644,0,644,
TCGA-A7-A4SF,BRCA,54,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19985,Alive,TUMOR FREE,545,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,545,0,545,NA,NA,0,545,
TCGA-A7-A56D,BRCA,84,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30783,Alive,TUMOR FREE,448,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,448,0,448,0,448,0,448,
TCGA-A7-A5ZV,BRCA,62,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Carcinoma NOS,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22966,Alive,TUMOR FREE,368,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,368,0,368,0,368,0,368,
TCGA-A7-A5ZW,BRCA,47,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,Peri (6-12 months since last menstrual period),-17529,Alive,TUMOR FREE,326,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,326,0,326,0,326,0,326,
TCGA-A7-A5ZX,BRCA,48,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17683,Alive,TUMOR FREE,336,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Unknown],NA,0,336,0,336,NA,NA,0,336,
TCGA-A7-A6VV,BRCA,51,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Peri (6-12 months since last menstrual period),-18695,Alive,TUMOR FREE,313,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,313,0,313,0,313,0,313,
TCGA-A7-A6VW,BRCA,48,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17539,Alive,TUMOR FREE,285,NA,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,0,285,0,285,NA,NA,0,285,
TCGA-A7-A6VX,BRCA,68,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25066,Alive,TUMOR FREE,317,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,317,0,317,0,317,0,317,
TCGA-A7-A6VY,BRCA,48,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17640,Alive,TUMOR FREE,266,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,266,0,266,0,266,0,266,
TCGA-A8-A06N,BRCA,66,FEMALE,[Not Available],Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24288,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,0,0,0,0,0,0,0,
TCGA-A8-A06O,BRCA,60,FEMALE,[Not Available],Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22157,Alive,TUMOR FREE,396,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,396,0,396,0,396,0,396,
TCGA-A8-A06P,BRCA,63,FEMALE,[Not Available],Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23011,Alive,TUMOR FREE,396,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,396,0,396,0,396,0,396,
TCGA-A8-A06Q,BRCA,63,FEMALE,[Not Available],Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23164,Alive,TUMOR FREE,31,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,31,0,31,0,31,0,31,
TCGA-A8-A06R,BRCA,69,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25477,Alive,TUMOR FREE,547,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,547,0,547,0,547,0,547,
TCGA-A8-A06T,BRCA,75,FEMALE,[Not Available],Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27393,Alive,TUMOR FREE,1614,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1614,0,1614,0,1614,0,1614,
TCGA-A8-A06U,BRCA,80,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29525,Dead,TUMOR FREE,NA,883,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,883,0,883,0,883,0,883,
TCGA-A8-A06X,BRCA,77,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28338,Dead,TUMOR FREE,NA,943,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,943,0,943,0,943,0,943,
TCGA-A8-A06Y,BRCA,66,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24442,Alive,TUMOR FREE,791,NA,[Not Available],NA,NA,NA,791,[Not Available],Negative,NA,0,791,0,791,1,791,1,791,
TCGA-A8-A06Z,BRCA,84,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30984,Alive,NA,31,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,31,0,31,NA,NA,0,31,
TCGA-A8-A075,BRCA,42,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15369,Alive,TUMOR FREE,518,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,518,0,518,0,518,0,518,
TCGA-A8-A076,BRCA,66,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24230,Alive,TUMOR FREE,1642,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1642,0,1642,0,1642,0,1642,
TCGA-A8-A079,BRCA,69,FEMALE,[Not Available],Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25294,Alive,TUMOR FREE,274,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,274,0,274,0,274,0,274,
TCGA-A8-A07B,BRCA,69,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25475,Alive,TUMOR FREE,1308,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1308,0,1308,0,1308,0,1308,
TCGA-A8-A07C,BRCA,57,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20820,Alive,TUMOR FREE,1034,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1034,0,1034,0,1034,0,1034,
TCGA-A8-A07E,BRCA,81,FEMALE,[Not Available],Stage X,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29800,Alive,TUMOR FREE,608,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,608,0,608,0,608,0,608,
TCGA-A8-A07F,BRCA,65,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23742,Alive,TUMOR FREE,577,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,577,0,577,0,577,0,577,
TCGA-A8-A07G,BRCA,65,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23926,Alive,TUMOR FREE,577,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,577,0,577,0,577,0,577,
TCGA-A8-A07I,BRCA,69,FEMALE,[Not Available],Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25263,Alive,TUMOR FREE,426,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,426,0,426,0,426,0,426,
TCGA-A8-A07J,BRCA,35,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12965,Alive,TUMOR FREE,365,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,365,0,365,0,365,0,365,
TCGA-A8-A07L,BRCA,58,FEMALE,[Not Available],Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21428,Alive,TUMOR FREE,975,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,975,0,975,0,975,0,975,
TCGA-A8-A07O,BRCA,51,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18870,Alive,TUMOR FREE,304,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,304,0,304,0,304,0,304,
TCGA-A8-A07P,BRCA,68,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24929,Alive,TUMOR FREE,334,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,334,0,334,0,334,0,334,
TCGA-A8-A07R,BRCA,80,FEMALE,[Not Available],Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,[Not Available],-29251,Alive,NA,273,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,273,0,273,NA,NA,0,273,
TCGA-A8-A07S,BRCA,73,FEMALE,[Not Available],Stage IIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26998,Alive,WITH TUMOR,243,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,243,0,243,NA,NA,0,243,
TCGA-A8-A07U,BRCA,66,FEMALE,[Not Available],Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24411,Alive,TUMOR FREE,760,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,760,0,760,0,760,0,760,
TCGA-A8-A07W,BRCA,76,FEMALE,[Not Available],Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27942,Alive,WITH TUMOR,304,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,304,0,304,NA,NA,0,304,
TCGA-A8-A07Z,BRCA,85,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31351,Alive,TUMOR FREE,1371,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1371,0,1371,0,1371,0,1371,
TCGA-A8-A081,BRCA,80,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29555,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,0,0,0,0,0,0,0,
TCGA-A8-A082,BRCA,58,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21338,Alive,TUMOR FREE,549,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,549,0,549,0,549,0,549,
TCGA-A8-A083,BRCA,67,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24746,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,0,0,0,0,0,0,0,
TCGA-A8-A084,BRCA,81,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29858,Alive,WITH TUMOR,458,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,458,0,458,NA,NA,0,458,
TCGA-A8-A085,BRCA,44,MALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,[Not Available],-16377,Alive,TUMOR FREE,1124,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1124,0,1124,0,1124,0,1124,
TCGA-A8-A086,BRCA,59,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21731,Alive,TUMOR FREE,396,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,396,0,396,0,396,0,396,
TCGA-A8-A08A,BRCA,89,FEMALE,[Not Available],Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32750,Alive,TUMOR FREE,30,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,30,0,30,0,30,0,30,
TCGA-A8-A08B,BRCA,52,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19114,Alive,TUMOR FREE,1156,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1156,0,1156,0,1156,0,1156,
TCGA-A8-A08C,BRCA,65,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24017,Alive,TUMOR FREE,881,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,881,0,881,0,881,0,881,
TCGA-A8-A08F,BRCA,59,FEMALE,[Not Available],Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21641,Alive,TUMOR FREE,1004,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1004,0,1004,0,1004,0,1004,
TCGA-A8-A08G,BRCA,41,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14976,Alive,TUMOR FREE,607,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,607,0,607,0,607,0,607,
TCGA-A8-A08H,BRCA,66,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24137,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,0,0,0,0,0,0,0,
TCGA-A8-A08I,BRCA,53,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19389,Alive,TUMOR FREE,365,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,365,0,365,0,365,0,365,
TCGA-A8-A08J,BRCA,52,FEMALE,[Not Available],Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19266,Dead,WITH TUMOR,NA,1127,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,1,1127,1,1127,NA,NA,1,1127,
TCGA-A8-A08L,BRCA,89,FEMALE,[Not Available],Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32842,Dead,TUMOR FREE,NA,304,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,304,0,304,0,304,0,304,
TCGA-A8-A08O,BRCA,45,FEMALE,[Not Available],Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16681,Alive,WITH TUMOR,943,NA,[Not Available],NA,NA,NA,762,[Not Available],Positive,NA,0,943,0,943,NA,NA,1,762,
TCGA-A8-A08P,BRCA,70,FEMALE,[Not Available],Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25598,Alive,TUMOR FREE,943,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,943,0,943,0,943,0,943,
TCGA-A8-A08R,BRCA,52,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19298,Alive,TUMOR FREE,30,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,30,0,30,0,30,0,30,
TCGA-A8-A08S,BRCA,71,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25994,Alive,TUMOR FREE,1004,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1004,0,1004,0,1004,0,1004,
TCGA-A8-A08T,BRCA,64,FEMALE,[Not Available],Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23560,Dead,WITH TUMOR,NA,3409,[Not Available],NA,NA,NA,2557,[Not Available],Positive,NA,1,3409,1,3409,NA,NA,1,2557,
TCGA-A8-A08X,BRCA,43,FEMALE,[Not Available],Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15705,Alive,TUMOR FREE,1308,NA,[Not Available],NA,NA,NA,366,[Not Available],Negative,NA,0,1308,0,1308,1,366,1,366,
TCGA-A8-A08Z,BRCA,76,FEMALE,[Not Available],[Discrepancy],[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28003,Alive,TUMOR FREE,1217,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1217,0,1217,0,1217,0,1217,
TCGA-A8-A090,BRCA,74,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27121,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,0,0,0,0,0,0,0,
TCGA-A8-A091,BRCA,61,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22554,Alive,TUMOR FREE,1004,NA,[Not Available],NA,NA,NA,243,[Not Available],Negative,NA,0,1004,0,1004,1,243,1,243,
TCGA-A8-A092,BRCA,48,FEMALE,[Not Available],Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17807,Alive,TUMOR FREE,942,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,942,0,942,0,942,0,942,
TCGA-A8-A093,BRCA,61,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22373,Alive,TUMOR FREE,546,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,546,0,546,0,546,0,546,
TCGA-A8-A094,BRCA,75,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27729,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,0,0,0,0,0,0,0,
TCGA-A8-A095,BRCA,45,FEMALE,[Not Available],Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16742,Alive,TUMOR FREE,1277,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1277,0,1277,0,1277,0,1277,
TCGA-A8-A096,BRCA,73,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26723,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,0,0,0,0,0,0,0,
TCGA-A8-A097,BRCA,65,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23741,Alive,TUMOR FREE,365,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,365,0,365,0,365,0,365,
TCGA-A8-A099,BRCA,76,FEMALE,[Not Available],Stage X,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28063,Alive,NA,304,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,304,0,304,NA,NA,0,304,
TCGA-A8-A09A,BRCA,40,FEMALE,[Not Available],Stage X,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14883,Alive,WITH TUMOR,304,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,304,0,304,NA,NA,0,304,
TCGA-A8-A09B,BRCA,58,FEMALE,[Not Available],Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21520,Alive,TUMOR FREE,365,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,365,0,365,0,365,0,365,
TCGA-A8-A09C,BRCA,69,FEMALE,[Not Available],Stage X,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25355,Alive,NA,31,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,31,0,31,NA,NA,0,31,
TCGA-A8-A09D,BRCA,47,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17440,Alive,TUMOR FREE,1522,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1522,0,1522,0,1522,0,1522,
TCGA-A8-A09E,BRCA,73,FEMALE,[Not Available],Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26724,Alive,WITH TUMOR,1492,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,1492,0,1492,NA,NA,0,1492,
TCGA-A8-A09G,BRCA,79,FEMALE,[Not Available],Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29006,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,0,0,0,0,0,0,0,
TCGA-A8-A09I,BRCA,84,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30711,Alive,TUMOR FREE,1371,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1371,0,1371,0,1371,0,1371,
TCGA-A8-A09K,BRCA,68,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24960,Alive,TUMOR FREE,912,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,912,0,912,0,912,0,912,
TCGA-A8-A09M,BRCA,75,FEMALE,[Not Available],Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27455,Alive,TUMOR FREE,1006,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1006,0,1006,0,1006,0,1006,
TCGA-A8-A09N,BRCA,57,FEMALE,[Not Available],Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21002,Alive,TUMOR FREE,31,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,31,0,31,0,31,0,31,
TCGA-A8-A09Q,BRCA,83,FEMALE,[Not Available],Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30528,Alive,WITH TUMOR,761,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,761,0,761,NA,NA,0,761,
TCGA-A8-A09R,BRCA,82,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30196,Alive,TUMOR FREE,273,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,273,0,273,0,273,0,273,
TCGA-A8-A09T,BRCA,68,FEMALE,[Not Available],[Discrepancy],[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25110,Alive,TUMOR FREE,579,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,579,0,579,0,579,0,579,
TCGA-A8-A09V,BRCA,51,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18628,Alive,TUMOR FREE,457,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,457,0,457,0,457,0,457,
TCGA-A8-A09W,BRCA,70,FEMALE,[Not Available],Stage IIIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25659,Alive,NA,30,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,30,0,30,NA,NA,0,30,
TCGA-A8-A09X,BRCA,62,FEMALE,[Not Available],Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22858,Dead,NA,NA,426,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,426,NA,426,NA,NA,0,426,
TCGA-A8-A09Z,BRCA,83,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30590,Alive,WITH TUMOR,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,0,0,0,NA,NA,0,0,
TCGA-A8-A0A1,BRCA,84,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30742,Alive,TUMOR FREE,365,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,365,0,365,0,365,0,365,
TCGA-A8-A0A2,BRCA,66,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24380,Alive,TUMOR FREE,579,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,579,0,579,0,579,0,579,
TCGA-A8-A0A4,BRCA,73,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26693,Alive,TUMOR FREE,396,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,396,0,396,0,396,0,396,
TCGA-A8-A0A6,BRCA,64,FEMALE,[Not Available],Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23404,Alive,TUMOR FREE,640,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,640,0,640,0,640,0,640,
TCGA-A8-A0A7,BRCA,57,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20940,Alive,TUMOR FREE,30,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,30,0,30,0,30,0,30,
TCGA-A8-A0A9,BRCA,80,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29370,Alive,TUMOR FREE,822,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,822,0,822,0,822,0,822,
TCGA-A8-A0AB,BRCA,54,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19814,Alive,TUMOR FREE,518,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,518,0,518,0,518,0,518,
TCGA-A8-A0AD,BRCA,83,FEMALE,[Not Available],Stage I,[Not Applicable],Mixed Histology (please specify),[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30407,Alive,TUMOR FREE,1157,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1157,0,1157,0,1157,0,1157,
TCGA-AC-A23C,BRCA,62,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22751,Alive,TUMOR FREE,585,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,585,0,585,0,585,0,585,
TCGA-AC-A23E,BRCA,50,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,[Not Available],-18500,Alive,TUMOR FREE,698,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,698,0,698,0,698,0,698,
TCGA-AC-A23G,BRCA,76,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27934,Alive,TUMOR FREE,2248,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2248,0,2248,0,2248,0,2248,
TCGA-AC-A23H,BRCA,90,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32873,Dead,WITH TUMOR,NA,174,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,174,1,174,NA,NA,1,174,
TCGA-AC-A2B8,BRCA,84,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31003,Alive,TUMOR FREE,677,NA,[Not Available],New Primary Tumor,"Other, specify",Rectum,654,[Not Available],Negative,NA,0,677,0,677,0,677,1,654,
TCGA-AC-A2BK,BRCA,78,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28625,Alive,TUMOR FREE,2222,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2222,0,2222,0,2222,0,2222,
TCGA-AC-A2BM,BRCA,41,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,[Not Available],-15212,Alive,TUMOR FREE,3022,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3022,0,3022,0,3022,0,3022,
TCGA-AC-A2FB,BRCA,65,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,[Not Available],-23851,Alive,TUMOR FREE,1234,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1234,0,1234,0,1234,0,1234,
TCGA-AC-A2FE,BRCA,62,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22746,Dead,WITH TUMOR,NA,2636,[Not Available],Distant Metastasis,Bone,NA,766,[Not Available],Negative,NA,1,2636,1,2636,1,766,1,766,
TCGA-AC-A2FF,BRCA,40,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006,[Not Available],NA,Alive,TUMOR FREE,2759,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2759,0,2759,0,2759,0,2759,
TCGA-AC-A2FG,BRCA,79,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29211,Alive,TUMOR FREE,1853,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1853,0,1853,0,1853,0,1853,
TCGA-AC-A2FK,BRCA,45,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006,[Not Available],-16627,Alive,TUMOR FREE,2650,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2650,0,2650,0,2650,0,2650,
TCGA-AC-A2FM,BRCA,87,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31805,Dead,WITH TUMOR,NA,792,[Not Available],Distant Metastasis,"Other, specify",Bone Marrow,780,[Not Available],Negative,NA,1,792,1,792,1,780,1,780,
TCGA-AC-A2FO,BRCA,65,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23928,Alive,TUMOR FREE,2255,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2255,0,2255,0,2255,0,2255,
TCGA-AC-A2QH,BRCA,58,FEMALE,WHITE,Stage IIB,[Not Applicable],Metaplastic Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21488,Alive,TUMOR FREE,1005,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1005,0,1005,0,1005,0,1005,
TCGA-AC-A2QI,BRCA,76,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27865,Alive,TUMOR FREE,588,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,588,0,588,0,588,0,588,
TCGA-AC-A2QJ,BRCA,48,FEMALE,WHITE,Stage IIIB,[Not Applicable],Metaplastic Carcinoma,[Not Available],2011,Peri (6-12 months since last menstrual period),-17569,Dead,WITH TUMOR,NA,446,[Not Available],Distant Metastasis,Bone,NA,237,[Not Available],Negative,NA,1,446,1,446,1,237,1,237,
TCGA-AC-A3BB,BRCA,46,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,[Not Available],-16983,Alive,TUMOR FREE,987,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,987,0,987,0,987,0,987,
TCGA-AC-A3EH,BRCA,79,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29014,Dead,TUMOR FREE,NA,197,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,197,0,197,0,197,0,197,
TCGA-AC-A3HN,BRCA,87,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32061,Alive,TUMOR FREE,496,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,496,0,496,0,496,0,496,
TCGA-AC-A3OD,BRCA,68,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25186,Alive,TUMOR FREE,451,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,451,0,451,0,451,0,451,
TCGA-AC-A3QP,BRCA,79,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29113,Alive,TUMOR FREE,675,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,675,0,675,0,675,0,675,
TCGA-AC-A3QQ,BRCA,54,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Peri (6-12 months since last menstrual period),-19723,Alive,TUMOR FREE,734,NA,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,0,734,0,734,NA,NA,0,734,
TCGA-AC-A3TM,BRCA,50,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Peri (6-12 months since last menstrual period),-18535,Alive,TUMOR FREE,762,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,762,0,762,0,762,0,762,
TCGA-AC-A3TN,BRCA,75,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27421,Alive,TUMOR FREE,456,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,456,0,456,0,456,0,456,
TCGA-AC-A3W5,BRCA,65,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,[Not Evaluated],-24029,Alive,TUMOR FREE,504,NA,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,0,504,0,504,NA,NA,0,504,
TCGA-AC-A3W6,BRCA,90,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872,Alive,TUMOR FREE,602,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,602,0,602,0,602,0,602,
TCGA-AC-A3W7,BRCA,66,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24327,Alive,TUMOR FREE,471,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,471,0,471,0,471,0,471,
TCGA-AC-A3YI,BRCA,74,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27143,Alive,TUMOR FREE,707,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,707,0,707,0,707,0,707,
TCGA-AC-A3YJ,BRCA,66,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24439,Alive,TUMOR FREE,754,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,754,0,754,0,754,0,754,
TCGA-AC-A4ZE,BRCA,63,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23284,Alive,TUMOR FREE,890,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,890,0,890,0,890,0,890,
TCGA-AC-A5EH,BRCA,76,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,[Not Available],-27964,Alive,TUMOR FREE,511,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,511,0,511,0,511,0,511,
TCGA-AC-A5EI,BRCA,88,FEMALE,WHITE,Stage IB,[Not Applicable],"Other, specify",[Not Available],2012,[Not Available],-32375,Alive,TUMOR FREE,442,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,442,0,442,0,442,0,442,
TCGA-AC-A5XS,BRCA,74,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,[Not Available],-27160,Alive,TUMOR FREE,588,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,588,0,588,0,588,0,588,
TCGA-AC-A5XU,BRCA,74,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,[Not Available],-27191,Alive,TUMOR FREE,455,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,455,0,455,0,455,0,455,
TCGA-AC-A62V,BRCA,58,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,[Not Evaluated],-21389,Dead,WITH TUMOR,NA,348,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,348,1,348,NA,NA,1,348,
TCGA-AC-A62X,BRCA,72,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26627,Alive,TUMOR FREE,417,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,417,0,417,0,417,0,417,
TCGA-AC-A62Y,BRCA,79,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28876,Alive,TUMOR FREE,530,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,530,0,530,NA,NA,0,530,
TCGA-AC-A6IV,BRCA,47,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,[Not Available],-17521,Alive,TUMOR FREE,568,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,568,0,568,0,568,0,568,
TCGA-AC-A6IW,BRCA,73,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26896,Alive,TUMOR FREE,413,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,413,0,413,0,413,0,413,
TCGA-AC-A6IX,BRCA,49,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013,Peri (6-12 months since last menstrual period),-17969,Alive,TUMOR FREE,373,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,373,0,373,0,373,0,373,
TCGA-AC-A6NO,BRCA,43,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,[Unknown],-15996,Alive,TUMOR FREE,51,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,51,0,51,0,51,0,51,
TCGA-AC-A7VB,BRCA,51,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,[Unknown],-18806,Alive,TUMOR FREE,250,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,250,0,250,0,250,0,250,
TCGA-AC-A7VC,BRCA,56,FEMALE,WHITE,Stage IIB,[Not Applicable],Metaplastic Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20479,Alive,TUMOR FREE,1,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1,0,1,0,1,0,1,
TCGA-AC-A8OP,BRCA,72,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26550,Alive,TUMOR FREE,614,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,614,0,614,0,614,0,614,
TCGA-AC-A8OQ,BRCA,72,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26535,Alive,TUMOR FREE,34,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,34,0,34,0,34,0,34,
TCGA-AC-A8OR,BRCA,75,FEMALE,WHITE,Stage IA,[Not Applicable],Mucinous Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27605,Alive,TUMOR FREE,40,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,40,0,40,0,40,0,40,
TCGA-AC-A8OS,BRCA,71,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26248,Alive,TUMOR FREE,70,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,70,0,70,0,70,0,70,
TCGA-AN-A03X,BRCA,74,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27163,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,10,0,10,0,10,0,10,
TCGA-AN-A03Y,BRCA,66,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24232,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,10,0,10,0,10,0,10,
TCGA-AN-A041,BRCA,29,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10812,Alive,TUMOR FREE,7,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,7,0,7,0,7,0,7,
TCGA-AN-A046,BRCA,68,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25158,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,10,0,10,0,10,0,10,
TCGA-AN-A049,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22710,Alive,TUMOR FREE,19,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,19,0,19,NA,NA,0,19,
TCGA-AN-A04A,BRCA,36,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Peri (6-12 months since last menstrual period),-13445,Alive,TUMOR FREE,90,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,90,0,90,NA,NA,0,90,
TCGA-AN-A04C,BRCA,51,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18851,Alive,TUMOR FREE,54,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,54,0,54,NA,NA,0,54,
TCGA-AN-A04D,BRCA,58,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21426,Alive,TUMOR FREE,52,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,52,0,52,NA,NA,0,52,
TCGA-AN-A0AJ,BRCA,79,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29131,Alive,TUMOR FREE,303,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,303,0,303,0,303,0,303,
TCGA-AN-A0AK,BRCA,76,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27977,Alive,TUMOR FREE,224,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,224,0,224,0,224,0,224,
TCGA-AN-A0AL,BRCA,41,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15286,Alive,TUMOR FREE,227,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,227,0,227,0,227,0,227,
TCGA-AN-A0AM,BRCA,56,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20713,Alive,TUMOR FREE,5,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,5,0,5,0,5,0,5,
TCGA-AN-A0AR,BRCA,55,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20152,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,10,0,10,0,10,0,10,
TCGA-AN-A0AS,BRCA,70,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25658,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,10,0,10,0,10,0,10,
TCGA-AN-A0AT,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22798,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,10,0,10,0,10,0,10,
TCGA-AN-A0FD,BRCA,71,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26007,Alive,TUMOR FREE,196,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,196,0,196,0,196,0,196,
TCGA-AN-A0FF,BRCA,32,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11929,Alive,TUMOR FREE,172,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,172,0,172,0,172,0,172,
TCGA-AN-A0FJ,BRCA,59,FEMALE,WHITE,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-21910,Alive,TUMOR FREE,242,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,242,0,242,NA,NA,0,242,
TCGA-AN-A0FK,BRCA,88,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32462,Alive,TUMOR FREE,213,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,213,0,213,0,213,0,213,
TCGA-AN-A0FL,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22805,Alive,TUMOR FREE,231,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,231,0,231,0,231,0,231,
TCGA-AN-A0FN,BRCA,61,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22629,Alive,TUMOR FREE,218,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,218,0,218,0,218,0,218,
TCGA-AN-A0FS,BRCA,55,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-20352,Alive,TUMOR FREE,210,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,210,0,210,0,210,0,210,
TCGA-AN-A0FT,BRCA,63,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23300,Alive,TUMOR FREE,214,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,214,0,214,0,214,0,214,
TCGA-AN-A0FV,BRCA,58,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21479,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,10,0,10,0,10,0,10,
TCGA-AN-A0FW,BRCA,67,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24692,Alive,TUMOR FREE,11,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,11,0,11,0,11,0,11,
TCGA-AN-A0FX,BRCA,52,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19309,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,10,0,10,0,10,0,10,
TCGA-AN-A0FY,BRCA,55,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20347,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,10,0,10,0,10,0,10,
TCGA-AN-A0FZ,BRCA,45,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16533,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,10,0,10,0,10,0,10,
TCGA-AN-A0G0,BRCA,56,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20504,Alive,TUMOR FREE,16,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,16,0,16,0,16,0,16,
TCGA-AN-A0XL,BRCA,61,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22341,Alive,TUMOR FREE,163,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,163,0,163,0,163,0,163,
TCGA-AN-A0XN,BRCA,68,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25029,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,10,0,10,0,10,0,10,
TCGA-AN-A0XO,BRCA,59,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21640,Alive,TUMOR FREE,375,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,375,0,375,0,375,0,375,
TCGA-AN-A0XP,BRCA,69,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25305,Alive,TUMOR FREE,9,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,9,0,9,0,9,0,9,
TCGA-AN-A0XR,BRCA,55,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20381,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,10,0,10,0,10,0,10,
TCGA-AN-A0XS,BRCA,63,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23358,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,10,0,10,0,10,0,10,
TCGA-AN-A0XT,BRCA,54,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19794,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,10,0,10,0,10,0,10,
TCGA-AN-A0XU,BRCA,54,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20052,Alive,TUMOR FREE,10,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,10,0,10,0,10,0,10,
TCGA-AN-A0XV,BRCA,67,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24779,Alive,TUMOR FREE,162,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,162,0,162,0,162,0,162,
TCGA-AN-A0XW,BRCA,36,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13208,Alive,TUMOR FREE,170,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,170,0,170,0,170,0,170,
TCGA-AO-A03L,BRCA,34,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12443,Alive,TUMOR FREE,2442,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2442,0,2442,0,2442,0,2442,
TCGA-AO-A03M,BRCA,29,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10616,Alive,TUMOR FREE,1866,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1866,0,1866,0,1866,0,1866,
TCGA-AO-A03N,BRCA,59,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21816,Alive,WITH TUMOR,2031,NA,[Not Available],Locoregional Disease,NA,NA,1645,[Not Available],Negative,NA,0,2031,0,2031,1,1645,1,1645,
TCGA-AO-A03O,BRCA,69,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25362,Dead,TUMOR FREE,NA,2483,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,2483,0,2483,0,2483,0,2483,
TCGA-AO-A03P,BRCA,54,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19724,Dead,WITH TUMOR,NA,2911,[Not Available],Distant Metastasis,Liver,NA,1922,[Not Available],Close,NA,1,2911,1,2911,NA,NA,1,1922,
TCGA-AO-A03R,BRCA,57,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20930,Alive,TUMOR FREE,2091,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2091,0,2091,0,2091,0,2091,
TCGA-AO-A03T,BRCA,42,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15540,Alive,TUMOR FREE,2124,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2124,0,2124,0,2124,0,2124,
TCGA-AO-A03U,BRCA,31,FEMALE,WHITE,Stage I,[Not Applicable],"Other, specify",[Not Available],2001,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11354,Dead,TUMOR FREE,NA,1793,[Not Available],New Primary Tumor,Lung,NA,1614,[Not Available],Negative,NA,1,1793,0,1793,0,1793,1,1614,
TCGA-AO-A03V,BRCA,41,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Peri (6-12 months since last menstrual period),-15284,Alive,TUMOR FREE,1351,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1351,0,1351,0,1351,0,1351,
TCGA-AO-A0J2,BRCA,41,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15324,Alive,TUMOR FREE,997,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,997,0,997,0,997,0,997,
TCGA-AO-A0J3,BRCA,67,FEMALE,WHITE,Stage IIB,[Not Applicable],"Other, specify",[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24519,Alive,TUMOR FREE,651,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,651,0,651,0,651,0,651,
TCGA-AO-A0J4,BRCA,41,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15052,Alive,TUMOR FREE,1587,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1587,0,1587,0,1587,0,1587,
TCGA-AO-A0J5,BRCA,48,FEMALE,WHITE,Stage IV,[Not Applicable],"Other, specify",[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17815,Dead,WITH TUMOR,NA,792,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,1,792,1,792,NA,NA,1,792,
TCGA-AO-A0J6,BRCA,61,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22462,Alive,TUMOR FREE,1140,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1140,0,1140,0,1140,0,1140,
TCGA-AO-A0J7,BRCA,71,FEMALE,WHITE,Stage IIB,[Not Applicable],"Other, specify",[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26281,Alive,TUMOR FREE,618,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,618,0,618,0,618,0,618,
TCGA-AO-A0J8,BRCA,61,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22284,Alive,TUMOR FREE,680,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,680,0,680,0,680,0,680,
TCGA-AO-A0J9,BRCA,61,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22642,Alive,WITH TUMOR,1613,NA,[Not Available],Distant Metastasis,Bone,NA,1066,[Not Available],Negative,NA,0,1613,0,1613,1,1066,1,1066,
TCGA-AO-A0JA,BRCA,36,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13307,Alive,WITH TUMOR,655,NA,[Not Available],Distant Metastasis,Bone,NA,143,[Not Available],Negative,NA,0,655,0,655,1,143,1,143,
TCGA-AO-A0JB,BRCA,50,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18561,Alive,TUMOR FREE,1542,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1542,0,1542,0,1542,0,1542,
TCGA-AO-A0JC,BRCA,64,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23404,Alive,TUMOR FREE,1547,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1547,0,1547,0,1547,0,1547,
TCGA-AO-A0JD,BRCA,59,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21831,Alive,TUMOR FREE,2190,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2190,0,2190,0,2190,0,2190,
TCGA-AO-A0JE,BRCA,53,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19516,Alive,TUMOR FREE,2335,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,2335,0,2335,NA,NA,0,2335,
TCGA-AO-A0JF,BRCA,68,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24923,Alive,TUMOR FREE,1980,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1980,0,1980,0,1980,0,1980,
TCGA-AO-A0JG,BRCA,49,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Other, specify",[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18021,Alive,TUMOR FREE,798,NA,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,0,798,0,798,NA,NA,0,798,
TCGA-AO-A0JI,BRCA,56,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20694,Alive,TUMOR FREE,1528,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1528,0,1528,0,1528,0,1528,
TCGA-AO-A0JJ,BRCA,54,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19758,Alive,TUMOR FREE,1887,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1887,0,1887,0,1887,0,1887,
TCGA-AO-A0JL,BRCA,59,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21895,Alive,TUMOR FREE,1683,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1683,0,1683,0,1683,0,1683,
TCGA-AO-A0JM,BRCA,40,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14653,Alive,TUMOR FREE,2184,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2184,0,2184,0,2184,0,2184,
TCGA-AO-A124,BRCA,38,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2002,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14174,Alive,TUMOR FREE,3506,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3506,0,3506,0,3506,0,3506,
TCGA-AO-A125,BRCA,72,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26466,Alive,TUMOR FREE,3456,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3456,0,3456,0,3456,0,3456,
TCGA-AO-A126,BRCA,39,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2002,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14264,Alive,TUMOR FREE,3307,NA,[Not Available],Locoregional Disease,NA,NA,267,[Not Available],Negative,NA,0,3307,0,3307,1,267,1,267,
TCGA-AO-A128,BRCA,61,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22340,Alive,TUMOR FREE,3248,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3248,0,3248,0,3248,0,3248,
TCGA-AO-A129,BRCA,29,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2002,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10898,Alive,TUMOR FREE,3286,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3286,0,3286,0,3286,0,3286,
TCGA-AO-A12A,BRCA,47,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17420,Alive,TUMOR FREE,3112,NA,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,0,3112,0,3112,NA,NA,0,3112,
TCGA-AO-A12B,BRCA,63,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23150,Alive,TUMOR FREE,2989,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2989,0,2989,0,2989,0,2989,
TCGA-AO-A12C,BRCA,42,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15469,Alive,TUMOR FREE,2372,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2372,0,2372,0,2372,0,2372,
TCGA-AO-A12D,BRCA,43,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15774,Alive,TUMOR FREE,2515,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2515,0,2515,0,2515,0,2515,
TCGA-AO-A12E,BRCA,51,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18721,Alive,TUMOR FREE,2142,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2142,0,2142,0,2142,0,2142,
TCGA-AO-A12F,BRCA,36,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13409,Alive,TUMOR FREE,1842,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1842,0,1842,0,1842,0,1842,
TCGA-AO-A12G,BRCA,75,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27705,Alive,TUMOR FREE,1639,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1639,0,1639,0,1639,0,1639,
TCGA-AO-A12H,BRCA,69,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-25515,Alive,TUMOR FREE,1234,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1234,0,1234,0,1234,0,1234,
TCGA-AO-A1KO,BRCA,46,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16817,Alive,TUMOR FREE,622,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,622,0,622,0,622,0,622,
TCGA-AO-A1KP,BRCA,77,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28247,Alive,TUMOR FREE,2953,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2953,0,2953,0,2953,0,2953,
TCGA-AO-A1KQ,BRCA,84,MALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,[Not Available],-30859,Alive,TUMOR FREE,1882,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1882,0,1882,0,1882,0,1882,
TCGA-AO-A1KR,BRCA,51,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18900,Alive,TUMOR FREE,2513,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2513,0,2513,0,2513,0,2513,
TCGA-AO-A1KS,BRCA,69,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25230,Alive,TUMOR FREE,350,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,350,0,350,0,350,0,350,
TCGA-AO-A1KT,BRCA,78,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28660,Alive,TUMOR FREE,541,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,541,0,541,0,541,0,541,
TCGA-AQ-A04H,BRCA,61,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22539,Alive,TUMOR FREE,754,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,754,0,754,0,754,0,754,
TCGA-AQ-A04J,BRCA,45,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16615,Alive,TUMOR FREE,819,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,819,0,819,0,819,0,819,
TCGA-AQ-A04L,BRCA,48,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2001,Peri (6-12 months since last menstrual period),-17759,Alive,TUMOR FREE,3957,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3957,0,3957,0,3957,0,3957,
TCGA-AQ-A0Y5,BRCA,70,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25793,Dead,TUMOR FREE,NA,172,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,172,0,172,0,172,0,172,
TCGA-AQ-A1H2,BRCA,84,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30958,Alive,TUMOR FREE,475,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,475,0,475,0,475,0,475,
TCGA-AQ-A1H3,BRCA,49,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18177,Alive,TUMOR FREE,989,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,989,0,989,0,989,0,989,
TCGA-AQ-A54N,BRCA,51,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18741,Alive,TUMOR FREE,78,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,78,0,78,0,78,0,78,
TCGA-AQ-A54O,BRCA,51,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,[Not Available],-18694,Alive,TUMOR FREE,1001,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1001,0,1001,0,1001,0,1001,
TCGA-AQ-A7U7,BRCA,55,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20239,Dead,TUMOR FREE,NA,584,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,584,0,584,0,584,0,584,
TCGA-AR-A0TP,BRCA,43,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15812,Alive,TUMOR FREE,4275,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,4275,0,4275,0,4275,0,4275,
TCGA-AR-A0TQ,BRCA,27,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9873,Alive,TUMOR FREE,2991,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2991,0,2991,0,2991,0,2991,
TCGA-AR-A0TR,BRCA,68,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25190,Dead,NA,NA,160,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,160,NA,160,0,160,0,160,
TCGA-AR-A0TS,BRCA,46,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17141,Alive,TUMOR FREE,2558,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2558,0,2558,0,2558,0,2558,
TCGA-AR-A0TT,BRCA,53,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19679,Alive,TUMOR FREE,3316,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3316,0,3316,0,3316,0,3316,
TCGA-AR-A0TU,BRCA,35,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13039,Alive,TUMOR FREE,709,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,709,0,709,0,709,0,709,
TCGA-AR-A0TV,BRCA,66,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24279,Alive,TUMOR FREE,2288,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2288,0,2288,0,2288,0,2288,
TCGA-AR-A0TW,BRCA,50,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18263,Alive,TUMOR FREE,3009,NA,[Not Available],NA,NA,NA,739,[Not Available],Negative,NA,0,3009,0,3009,1,739,1,739,
TCGA-AR-A0TX,BRCA,64,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23653,Alive,TUMOR FREE,1972,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1972,0,1972,0,1972,0,1972,
TCGA-AR-A0TY,BRCA,54,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19836,Dead,WITH TUMOR,NA,1699,[Not Available],Distant Metastasis,Bone,NA,544,[Not Available],Negative,NA,1,1699,1,1699,1,544,1,544,
TCGA-AR-A0TZ,BRCA,43,FEMALE,WHITE,[Discrepancy],[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15720,Dead,NA,NA,3262,[Not Available],Distant Metastasis,Bone,NA,1313,[Not Available],Negative,NA,1,3262,NA,3262,1,1313,1,1313,
TCGA-AR-A0U0,BRCA,73,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26993,Alive,TUMOR FREE,1988,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1988,0,1988,0,1988,0,1988,
TCGA-AR-A0U1,BRCA,36,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13467,Alive,TUMOR FREE,4052,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,4052,0,4052,0,4052,0,4052,
TCGA-AR-A0U2,BRCA,47,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17390,Dead,WITH TUMOR,NA,2551,[Not Available],Distant Metastasis,Bone,Liver,1609,[Not Available],Negative,NA,1,2551,1,2551,1,1609,1,1609,
TCGA-AR-A0U3,BRCA,59,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21755,Alive,TUMOR FREE,4080,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,4080,0,4080,0,4080,0,4080,
TCGA-AR-A0U4,BRCA,54,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19729,Alive,TUMOR FREE,3261,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3261,0,3261,0,3261,0,3261,
TCGA-AR-A1AH,BRCA,51,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18991,Alive,TUMOR FREE,3807,NA,[Not Available],New Primary Tumor,"Other, specify",Renal,1136,[Not Available],Negative,NA,0,3807,0,3807,0,3807,1,1136,
TCGA-AR-A1AI,BRCA,47,FEMALE,WHITE,Stage IIA,[Not Applicable],Medullary Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17229,Alive,TUMOR FREE,3296,NA,[Not Available],New Primary Tumor,"Other, specify",Contralateral Breast,588,[Not Available],Negative,NA,0,3296,0,3296,1,588,1,588,
TCGA-AR-A1AJ,BRCA,83,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30489,Alive,TUMOR FREE,3072,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3072,0,3072,0,3072,0,3072,
TCGA-AR-A1AK,BRCA,70,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25825,Alive,TUMOR FREE,3159,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3159,0,3159,0,3159,0,3159,
TCGA-AR-A1AL,BRCA,60,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22023,Alive,TUMOR FREE,2971,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2971,0,2971,0,2971,0,2971,
TCGA-AR-A1AM,BRCA,52,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19123,Alive,TUMOR FREE,2991,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2991,0,2991,0,2991,0,2991,
TCGA-AR-A1AN,BRCA,46,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16974,Alive,TUMOR FREE,2920,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2920,0,2920,0,2920,0,2920,
TCGA-AR-A1AO,BRCA,47,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17332,Alive,TUMOR FREE,2618,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2618,0,2618,0,2618,0,2618,
TCGA-AR-A1AP,BRCA,80,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29406,Alive,TUMOR FREE,2856,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2856,0,2856,0,2856,0,2856,
TCGA-AR-A1AQ,BRCA,49,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18109,Alive,TUMOR FREE,3021,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3021,0,3021,0,3021,0,3021,
TCGA-AR-A1AR,BRCA,50,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18482,Dead,WITH TUMOR,NA,524,[Not Available],New Primary Tumor,"Other, specify",Breast,268,[Not Available],Negative,NA,1,524,1,524,1,268,1,268,
TCGA-AR-A1AS,BRCA,54,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20028,Alive,TUMOR FREE,1150,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1150,0,1150,0,1150,0,1150,
TCGA-AR-A1AT,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22942,Dead,NA,NA,1272,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,1272,NA,1272,0,1272,0,1272,
TCGA-AR-A1AU,BRCA,39,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14564,Alive,TUMOR FREE,2868,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2868,0,2868,0,2868,0,2868,
TCGA-AR-A1AV,BRCA,68,MALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,[Not Available],-24875,Alive,TUMOR FREE,1864,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1864,0,1864,0,1864,0,1864,
TCGA-AR-A1AW,BRCA,65,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23855,Alive,TUMOR FREE,2632,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2632,0,2632,0,2632,0,2632,
TCGA-AR-A1AX,BRCA,64,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23507,Alive,TUMOR FREE,2629,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2629,0,2629,0,2629,0,2629,
TCGA-AR-A1AY,BRCA,65,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23927,Alive,TUMOR FREE,1026,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1026,0,1026,0,1026,0,1026,
TCGA-AR-A24H,BRCA,65,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2001,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24046,Alive,TUMOR FREE,4894,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,4894,0,4894,0,4894,0,4894,
TCGA-AR-A24K,BRCA,46,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16961,Alive,TUMOR FREE,1548,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1548,0,1548,0,1548,0,1548,
TCGA-AR-A24L,BRCA,26,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9706,Dead,WITH TUMOR,NA,2866,[Not Available],Locoregional Disease,NA,NA,1414,[Not Available],Negative,NA,1,2866,1,2866,1,1414,1,1414,
TCGA-AR-A24M,BRCA,38,FEMALE,WHITE,Stage IIIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14119,Alive,TUMOR FREE,3660,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3660,0,3660,0,3660,0,3660,
TCGA-AR-A24N,BRCA,54,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Peri (6-12 months since last menstrual period),-19989,Alive,TUMOR FREE,3035,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3035,0,3035,0,3035,0,3035,
TCGA-AR-A24O,BRCA,43,FEMALE,WHITE,Stage IIIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15977,Alive,WITH TUMOR,3607,NA,[Not Available],NA,NA,NA,2561,[Not Available],Negative,NA,0,3607,0,3607,1,2561,1,2561,
TCGA-AR-A24P,BRCA,47,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17490,Alive,NA,84,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,84,0,84,0,84,0,84,
TCGA-AR-A24Q,BRCA,49,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18084,Alive,TUMOR FREE,3172,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3172,0,3172,0,3172,0,3172,
TCGA-AR-A24R,BRCA,45,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16642,Alive,TUMOR FREE,3430,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3430,0,3430,0,3430,0,3430,
TCGA-AR-A24S,BRCA,61,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22587,Alive,NA,2976,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2976,0,2976,0,2976,0,2976,
TCGA-AR-A24T,BRCA,46,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17135,Alive,TUMOR FREE,3202,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3202,0,3202,0,3202,0,3202,
TCGA-AR-A24U,BRCA,47,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17523,Alive,TUMOR FREE,3128,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3128,0,3128,0,3128,0,3128,
TCGA-AR-A24V,BRCA,52,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Peri (6-12 months since last menstrual period),-19027,Alive,TUMOR FREE,3203,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3203,0,3203,0,3203,0,3203,
TCGA-AR-A24W,BRCA,55,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20123,Alive,TUMOR FREE,1550,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1550,0,1550,0,1550,0,1550,
TCGA-AR-A24X,BRCA,52,FEMALE,WHITE,Stage IIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19030,Alive,TUMOR FREE,3004,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3004,0,3004,0,3004,0,3004,
TCGA-AR-A24Z,BRCA,57,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20900,Alive,TUMOR FREE,3001,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3001,0,3001,0,3001,0,3001,
TCGA-AR-A250,BRCA,58,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21309,Alive,TUMOR FREE,2707,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2707,0,2707,0,2707,0,2707,
TCGA-AR-A251,BRCA,51,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18771,Alive,TUMOR FREE,3030,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3030,0,3030,0,3030,0,3030,
TCGA-AR-A252,BRCA,50,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18611,Alive,TUMOR FREE,2838,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2838,0,2838,0,2838,0,2838,
TCGA-AR-A254,BRCA,50,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18270,Alive,TUMOR FREE,2605,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2605,0,2605,0,2605,0,2605,
TCGA-AR-A255,BRCA,62,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22809,Alive,TUMOR FREE,2161,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2161,0,2161,0,2161,0,2161,
TCGA-AR-A256,BRCA,45,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2001,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16642,Dead,NA,NA,2854,[Not Available],Locoregional Disease,NA,NA,1640,[Not Available],Negative,NA,1,2854,NA,2854,1,1640,1,1640,
TCGA-AR-A2LE,BRCA,69,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2001,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25499,Alive,TUMOR FREE,5062,NA,[Not Available],New Primary Tumor,"Other, specify",Endometrium,4203,[Not Available],Negative,NA,0,5062,0,5062,0,5062,1,4203,
TCGA-AR-A2LH,BRCA,55,FEMALE,WHITE,Stage III,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20288,Dead,NA,NA,616,[Not Available],Distant Metastasis,Bone,NA,434,[Not Available],Negative,NA,1,616,NA,616,1,434,1,434,
TCGA-AR-A2LJ,BRCA,40,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14723,Alive,TUMOR FREE,2632,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2632,0,2632,0,2632,0,2632,
TCGA-AR-A2LK,BRCA,62,FEMALE,WHITE,Stage III,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22800,Dead,NA,NA,1649,[Not Available],Distant Metastasis,Bone,NA,1304,[Not Available],Negative,NA,1,1649,NA,1649,1,1304,1,1304,
TCGA-AR-A2LL,BRCA,70,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25747,Alive,TUMOR FREE,2012,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2012,0,2012,0,2012,0,2012,
TCGA-AR-A2LM,BRCA,49,FEMALE,WHITE,Stage II,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18053,Alive,TUMOR FREE,1935,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1935,0,1935,0,1935,0,1935,
TCGA-AR-A2LN,BRCA,65,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23992,Alive,TUMOR FREE,1161,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1161,0,1161,0,1161,0,1161,
TCGA-AR-A2LO,BRCA,46,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17080,Alive,TUMOR FREE,1198,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1198,0,1198,0,1198,0,1198,
TCGA-AR-A2LQ,BRCA,59,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21865,Alive,TUMOR FREE,1233,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1233,0,1233,0,1233,0,1233,
TCGA-AR-A2LR,BRCA,49,FEMALE,WHITE,Stage I,[Not Applicable],Metaplastic Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18214,Alive,TUMOR FREE,1742,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1742,0,1742,0,1742,0,1742,
TCGA-AR-A5QM,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22780,Alive,TUMOR FREE,2231,NA,[Not Available],New Primary Tumor,"Other, specify",Malignant melanoma,968,[Not Available],[Not Available],NA,0,2231,0,2231,NA,NA,1,968,
TCGA-AR-A5QN,BRCA,68,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25089,Alive,TUMOR FREE,1013,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,1013,0,1013,NA,NA,0,1013,
TCGA-AR-A5QP,BRCA,54,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19805,Alive,TUMOR FREE,1185,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,1185,0,1185,NA,NA,0,1185,
TCGA-AR-A5QQ,BRCA,68,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Other, specify",[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24841,Dead,WITH TUMOR,NA,322,[Not Available],Distant Metastasis,Lung,"Liver, bone, chest wall, adrenal glands",301,[Not Available],[Not Available],NA,1,322,1,322,NA,NA,1,301,
TCGA-B6-A0I1,BRCA,73,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26902,Dead,TUMOR FREE,NA,2361,[Not Available],Distant Metastasis,Lung,NA,1120,[Not Available],Negative,NA,1,2361,0,2361,1,1120,1,1120,
TCGA-B6-A0I2,BRCA,45,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1995,Indeterminate (neither Pre or Postmenopausal),-16702,Alive,TUMOR FREE,4361,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,4361,0,4361,NA,NA,0,4361,
TCGA-B6-A0I5,BRCA,49,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1988,Indeterminate (neither Pre or Postmenopausal),-18038,Alive,TUMOR FREE,8556,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,8556,0,8556,0,8556,0,8556,
TCGA-B6-A0I6,BRCA,49,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1990,Indeterminate (neither Pre or Postmenopausal),-18014,Dead,WITH TUMOR,NA,991,[Not Available],Distant Metastasis,"Other, specify",Skin and bone,859,[Not Available],Negative,NA,1,991,1,991,1,859,1,859,
TCGA-B6-A0I8,BRCA,46,FEMALE,WHITE,Stage X,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1992,Indeterminate (neither Pre or Postmenopausal),-17073,Dead,WITH TUMOR,NA,749,[Not Available],Locoregional Disease,"Other, specify",Pectoral muscle,746,[Not Available],[Not Available],NA,1,749,1,749,NA,NA,1,746,
TCGA-B6-A0I9,BRCA,62,FEMALE,WHITE,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1992,Indeterminate (neither Pre or Postmenopausal),-22798,Dead,WITH TUMOR,NA,362,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,362,1,362,NA,NA,1,362,
TCGA-B6-A0IA,BRCA,51,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],1992,Indeterminate (neither Pre or Postmenopausal),-18748,Alive,TUMOR FREE,8391,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,8391,0,8391,0,8391,0,8391,
TCGA-B6-A0IB,BRCA,64,FEMALE,WHITE,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1992,Indeterminate (neither Pre or Postmenopausal),-23646,Dead,WITH TUMOR,NA,3941,[Not Available],Distant Metastasis,"Other, specify","lung, bone, liver",2717,[Not Available],Negative,NA,1,3941,1,3941,NA,NA,1,2717,
TCGA-B6-A0IC,BRCA,90,FEMALE,WHITE,Stage X,[Not Applicable],"Other, specify",[Not Available],1992,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872,Dead,TUMOR FREE,NA,1542,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,1542,0,1542,0,1542,0,1542,
TCGA-B6-A0IE,BRCA,38,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Mixed Histology (please specify),[Not Available],1995,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13982,Dead,WITH TUMOR,NA,1993,[Not Available],Distant Metastasis,Bone,NA,834,[Not Available],Negative,NA,1,1993,1,1993,1,834,1,834,
TCGA-B6-A0IG,BRCA,50,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1994,Indeterminate (neither Pre or Postmenopausal),-18433,Dead,WITH TUMOR,NA,4456,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,4456,1,4456,NA,NA,1,4456,
TCGA-B6-A0IH,BRCA,81,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],1995,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29907,Dead,NA,NA,3418,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,3418,NA,3418,0,3418,0,3418,
TCGA-B6-A0IJ,BRCA,42,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1995,Indeterminate (neither Pre or Postmenopausal),-15625,Alive,TUMOR FREE,7106,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,7106,0,7106,0,7106,0,7106,
TCGA-B6-A0IK,BRCA,63,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1994,Indeterminate (neither Pre or Postmenopausal),-23150,Dead,WITH TUMOR,NA,571,[Not Available],Distant Metastasis,Brain,NA,489,[Not Available],Negative,NA,1,571,1,571,1,489,1,489,
TCGA-B6-A0IM,BRCA,75,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],"Other, specify",[Not Available],1997,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27557,Dead,TUMOR FREE,NA,3873,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,3873,0,3873,0,3873,0,3873,
TCGA-B6-A0IN,BRCA,45,FEMALE,WHITE,Stage X,[Not Applicable],"Other, specify",[Not Available],1996,Indeterminate (neither Pre or Postmenopausal),-16705,Dead,WITH TUMOR,NA,2573,[Not Available],Distant Metastasis,"Other, specify","bone, brain",1412,[Not Available],Negative,NA,1,2573,1,2573,1,1412,1,1412,
TCGA-B6-A0IO,BRCA,66,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2001,Indeterminate (neither Pre or Postmenopausal),-24322,Alive,TUMOR FREE,5042,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,5042,0,5042,0,5042,0,5042,
TCGA-B6-A0IP,BRCA,74,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],1997,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27047,Dead,TUMOR FREE,NA,3926,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,3926,0,3926,0,3926,0,3926,
TCGA-B6-A0IQ,BRCA,40,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1996,Indeterminate (neither Pre or Postmenopausal),-14669,Alive,TUMOR FREE,4285,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,4285,0,4285,0,4285,0,4285,
TCGA-B6-A0RE,BRCA,61,FEMALE,BLACK OR AFRICAN AMERICAN,Stage X,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1989,Indeterminate (neither Pre or Postmenopausal),-22449,Alive,TUMOR FREE,7777,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,7777,0,7777,0,7777,0,7777,
TCGA-B6-A0RG,BRCA,26,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1991,Indeterminate (neither Pre or Postmenopausal),-9840,Alive,TUMOR FREE,2082,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2082,0,2082,0,2082,0,2082,
TCGA-B6-A0RH,BRCA,51,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1991,Indeterminate (neither Pre or Postmenopausal),-18759,Dead,TUMOR FREE,NA,6456,[Not Available],Locoregional Disease,"Other, specify",Chest Wall,2165,[Not Available],Negative,NA,1,6456,0,6456,1,2165,1,2165,
TCGA-B6-A0RI,BRCA,44,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1992,Indeterminate (neither Pre or Postmenopausal),-16138,Alive,WITH TUMOR,7126,NA,[Not Available],Locoregional Disease,"Other, specify",Chest Wall,1100,[Not Available],Negative,NA,0,7126,0,7126,1,1100,1,1100,
TCGA-B6-A0RL,BRCA,60,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1993,[Not Available],-22238,Dead,TUMOR FREE,NA,2469,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,2469,0,2469,0,2469,0,2469,
TCGA-B6-A0RM,BRCA,57,FEMALE,BLACK OR AFRICAN AMERICAN,Stage X,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1993,Indeterminate (neither Pre or Postmenopausal),-21047,Dead,TUMOR FREE,NA,2373,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,2373,0,2373,NA,NA,0,2373,
TCGA-B6-A0RN,BRCA,60,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1993,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22077,Alive,TUMOR FREE,8008,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,8008,0,8008,0,8008,0,8008,
TCGA-B6-A0RO,BRCA,71,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1993,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26269,Alive,TUMOR FREE,4929,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,4929,0,4929,0,4929,0,4929,
TCGA-B6-A0RP,BRCA,73,FEMALE,WHITE,[Discrepancy],[Not Applicable],Mixed Histology (please specify),[Not Available],1994,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26941,Dead,WITH TUMOR,NA,3126,[Not Available],Distant Metastasis,Bone,NA,2787,[Not Available],Negative,NA,1,3126,1,3126,1,2787,1,2787,
TCGA-B6-A0RQ,BRCA,68,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],1994,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25010,Dead,TUMOR FREE,NA,4267,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,4267,0,4267,0,4267,0,4267,
TCGA-B6-A0RS,BRCA,38,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1988,Indeterminate (neither Pre or Postmenopausal),-14134,Dead,WITH TUMOR,NA,3063,[Not Available],New Primary Tumor,"Other, specify",Breast,2041,[Not Available],Negative,NA,1,3063,1,3063,1,2041,1,2041,
TCGA-B6-A0RT,BRCA,39,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1996,Indeterminate (neither Pre or Postmenopausal),-14374,Alive,TUMOR FREE,2721,NA,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,0,2721,0,2721,NA,NA,0,2721,
TCGA-B6-A0RU,BRCA,40,FEMALE,WHITE,Stage IA,[Not Applicable],"Other, specify",[Not Available],1990,Indeterminate (neither Pre or Postmenopausal),-14920,Alive,TUMOR FREE,8605,NA,[Not Available],New Primary Tumor,"Other, specify",Right Breast,3076,[Not Available],Negative,NA,0,8605,0,8605,1,3076,1,3076,
TCGA-B6-A0RV,BRCA,42,FEMALE,WHITE,Stage IIIA,[Not Applicable],Mixed Histology (please specify),[Not Available],1996,Indeterminate (neither Pre or Postmenopausal),-15507,Alive,TUMOR FREE,5156,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,5156,0,5156,0,5156,0,5156,
TCGA-B6-A0WS,BRCA,58,FEMALE,BLACK OR AFRICAN AMERICAN,Stage X,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1996,Indeterminate (neither Pre or Postmenopausal),-21230,Dead,TUMOR FREE,NA,2965,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,1,2965,0,2965,NA,NA,0,2965,
TCGA-B6-A0WT,BRCA,61,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1995,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22362,Alive,TUMOR FREE,5739,NA,[Not Available],New Primary Tumor,"Other, specify",right breast cancer contralateral,3862,[Not Available],Negative,NA,0,5739,0,5739,1,3862,1,3862,
TCGA-B6-A0WV,BRCA,67,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1995,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24803,Dead,TUMOR FREE,NA,2417,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,2417,0,2417,0,2417,0,2417,
TCGA-B6-A0WW,BRCA,58,FEMALE,BLACK OR AFRICAN AMERICAN,Stage X,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1997,Indeterminate (neither Pre or Postmenopausal),-21479,Dead,WITH TUMOR,NA,558,[Not Available],Distant Metastasis,Liver,NA,447,[Not Available],Negative,NA,1,558,1,558,1,447,1,447,
TCGA-B6-A0WX,BRCA,40,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],"Other, specify",[Not Available],1998,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14784,Dead,WITH TUMOR,NA,639,[Not Available],Distant Metastasis,Bone,NA,563,[Not Available],Negative,NA,1,639,1,639,1,563,1,563,
TCGA-B6-A0WY,BRCA,40,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1996,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14778,Dead,WITH TUMOR,NA,3461,[Not Available],Distant Metastasis,Bone,NA,2011,[Not Available],Negative,NA,1,3461,1,3461,1,2011,1,2011,
TCGA-B6-A0WZ,BRCA,50,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1996,Indeterminate (neither Pre or Postmenopausal),-18584,Alive,TUMOR FREE,6292,NA,[Not Available],New Primary Tumor,Bone,NA,5117,[Not Available],Negative,NA,0,6292,0,6292,0,6292,1,5117,
TCGA-B6-A0X0,BRCA,54,FEMALE,WHITE,Stage I,[Not Applicable],"Other, specify",[Not Available],1996,Indeterminate (neither Pre or Postmenopausal),-19802,Dead,NA,NA,3945,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,3945,NA,3945,0,3945,0,3945,
TCGA-B6-A0X1,BRCA,48,FEMALE,WHITE,[Discrepancy],[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1994,Indeterminate (neither Pre or Postmenopausal),-17624,Dead,TUMOR FREE,NA,7455,[Not Available],Distant Metastasis,Brain,NA,490,[Not Available],Negative,NA,1,7455,0,7455,1,490,1,490,
TCGA-B6-A0X4,BRCA,62,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1996,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22688,Dead,WITH TUMOR,NA,860,[Not Available],Distant Metastasis,Bone,NA,716,[Not Available],Negative,NA,1,860,1,860,1,716,1,716,
TCGA-B6-A0X5,BRCA,61,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1995,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22380,Dead,WITH TUMOR,NA,2097,[Not Available],Distant Metastasis,"Other, specify",Liver and Pleura and Bone,1343,[Not Available],Negative,NA,1,2097,1,2097,1,1343,1,1343,
TCGA-B6-A0X7,BRCA,62,FEMALE,WHITE,Stage X,[Not Applicable],Mixed Histology (please specify),[Not Available],1994,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22723,Dead,TUMOR FREE,NA,1781,[Not Available],New Primary Tumor,"Other, specify",colon,1104,[Not Available],[Not Available],NA,1,1781,0,1781,NA,NA,1,1104,
TCGA-B6-A1KC,BRCA,67,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24791,Alive,TUMOR FREE,1326,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1326,0,1326,0,1326,0,1326,
TCGA-B6-A1KF,BRCA,68,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24891,Alive,TUMOR FREE,3088,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3088,0,3088,0,3088,0,3088,
TCGA-B6-A1KI,BRCA,63,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23031,Alive,TUMOR FREE,2236,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2236,0,2236,0,2236,0,2236,
TCGA-B6-A1KN,BRCA,57,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21183,Alive,TUMOR FREE,4233,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,4233,0,4233,0,4233,0,4233,
TCGA-B6-A2IU,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],1998,Indeterminate (neither Pre or Postmenopausal),-22905,Alive,WITH TUMOR,5176,NA,[Not Available],New Primary Tumor,"Other, specify",Lung,4224,[Not Available],Negative,NA,0,5176,0,5176,0,5176,1,4224,
TCGA-B6-A3ZX,BRCA,50,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Mixed Histology (please specify),[Not Available],2007,[Unknown],-18434,Dead,WITH TUMOR,NA,1152,[Not Available],Distant Metastasis,Bone,NA,994,[Not Available],Negative,NA,1,1152,1,1152,NA,NA,1,994,
TCGA-B6-A400,BRCA,43,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,[Unknown],-16022,Alive,TUMOR FREE,215,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,215,0,215,0,215,0,215,
TCGA-B6-A401,BRCA,47,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,[Unknown],-17438,Alive,TUMOR FREE,2596,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2596,0,2596,0,2596,0,2596,
TCGA-B6-A402,BRCA,47,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,[Unknown],-17314,Alive,WITH TUMOR,2281,NA,[Not Available],Locoregional Recurrence,"Other, specify",breast,1516,[Not Available],Negative,NA,0,2281,0,2281,1,1516,1,1516,
TCGA-B6-A408,BRCA,55,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Mixed Histology (please specify),[Not Available],2008,[Unknown],-20102,Alive,TUMOR FREE,2072,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2072,0,2072,0,2072,0,2072,
TCGA-B6-A409,BRCA,44,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16178,Dead,WITH TUMOR,NA,573,[Not Available],Distant Metastasis,Lung,NA,456,[Not Available],Negative,NA,1,573,1,573,1,456,1,456,
TCGA-B6-A40B,BRCA,76,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27811,Alive,TUMOR FREE,3152,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3152,0,3152,0,3152,0,3152,
TCGA-B6-A40C,BRCA,51,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2005,[Unknown],-18852,Alive,TUMOR FREE,2164,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2164,0,2164,0,2164,0,2164,
TCGA-BH-A0AU,BRCA,45,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16688,Alive,TUMOR FREE,1914,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1914,0,1914,0,1914,0,1914,
TCGA-BH-A0AV,BRCA,52,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,[Not Available],-19314,Alive,TUMOR FREE,1820,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1820,0,1820,0,1820,0,1820,
TCGA-BH-A0AW,BRCA,56,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20468,Alive,TUMOR FREE,622,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,622,0,622,0,622,0,622,
TCGA-BH-A0AY,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22703,Alive,TUMOR FREE,777,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,777,0,777,0,777,0,777,
TCGA-BH-A0AZ,BRCA,47,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17465,Alive,TUMOR FREE,1919,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1919,0,1919,0,1919,0,1919,
TCGA-BH-A0B0,BRCA,56,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Peri (6-12 months since last menstrual period),-20776,Alive,TUMOR FREE,2477,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2477,0,2477,0,2477,0,2477,
TCGA-BH-A0B1,BRCA,66,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24315,Alive,TUMOR FREE,1148,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1148,0,1148,0,1148,0,1148,
TCGA-BH-A0B3,BRCA,53,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19479,Alive,TUMOR FREE,1203,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1203,0,1203,0,1203,0,1203,
TCGA-BH-A0B4,BRCA,65,MALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,[Not Available],-23980,Alive,TUMOR FREE,1191,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1191,0,1191,0,1191,0,1191,
TCGA-BH-A0B5,BRCA,40,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14920,Alive,TUMOR FREE,2136,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,2136,0,2136,NA,NA,0,2136,
TCGA-BH-A0B6,BRCA,47,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,[Not Available],-17346,Alive,TUMOR FREE,2483,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2483,0,2483,0,2483,0,2483,
TCGA-BH-A0B7,BRCA,42,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15593,Alive,TUMOR FREE,2559,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2559,0,2559,0,2559,0,2559,
TCGA-BH-A0B8,BRCA,64,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23380,Alive,TUMOR FREE,1569,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1569,0,1569,0,1569,0,1569,
TCGA-BH-A0B9,BRCA,44,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16310,Alive,TUMOR FREE,1572,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1572,0,1572,0,1572,0,1572,
TCGA-BH-A0BA,BRCA,51,FEMALE,WHITE,Stage IIIC,[Not Applicable],Mixed Histology (please specify),[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18839,Alive,TUMOR FREE,1132,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1132,0,1132,0,1132,0,1132,
TCGA-BH-A0BC,BRCA,60,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21949,Alive,TUMOR FREE,974,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,974,0,974,0,974,0,974,
TCGA-BH-A0BD,BRCA,47,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17275,Alive,TUMOR FREE,554,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,554,0,554,0,554,0,554,
TCGA-BH-A0BF,BRCA,56,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20691,Dead,TUMOR FREE,NA,1324,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,1324,0,1324,0,1324,0,1324,
TCGA-BH-A0BG,BRCA,73,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26988,Alive,TUMOR FREE,1871,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1871,0,1871,0,1871,0,1871,
TCGA-BH-A0BJ,BRCA,41,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15027,Alive,TUMOR FREE,660,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,660,0,660,0,660,0,660,
TCGA-BH-A0BL,BRCA,35,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12841,Alive,TUMOR FREE,2278,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2278,0,2278,0,2278,0,2278,
TCGA-BH-A0BM,BRCA,54,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20049,Alive,TUMOR FREE,1876,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1876,0,1876,0,1876,0,1876,
TCGA-BH-A0BO,BRCA,54,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19767,Alive,TUMOR FREE,2197,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2197,0,2197,0,2197,0,2197,
TCGA-BH-A0BP,BRCA,76,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27917,Dead,TUMOR FREE,NA,2296,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,2296,0,2296,0,2296,0,2296,
TCGA-BH-A0BQ,BRCA,39,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14494,Alive,TUMOR FREE,2255,NA,[Not Available],Locoregional Recurrence,"Other, specify",Dermis and epidermis,1709,[Not Available],Negative,NA,0,2255,0,2255,1,1709,1,1709,
TCGA-BH-A0BR,BRCA,59,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21622,Alive,TUMOR FREE,2330,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2330,0,2330,0,2330,0,2330,
TCGA-BH-A0BS,BRCA,55,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20374,Alive,TUMOR FREE,2612,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2612,0,2612,0,2612,0,2612,
TCGA-BH-A0BT,BRCA,56,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,[Not Available],-20625,Alive,TUMOR FREE,2365,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2365,0,2365,0,2365,0,2365,
TCGA-BH-A0BV,BRCA,78,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28699,Alive,TUMOR FREE,1519,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1519,0,1519,0,1519,0,1519,
TCGA-BH-A0BW,BRCA,71,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25974,Alive,TUMOR FREE,2371,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2371,0,2371,0,2371,0,2371,
TCGA-BH-A0BZ,BRCA,59,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21856,Alive,TUMOR FREE,2255,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2255,0,2255,0,2255,0,2255,
TCGA-BH-A0C0,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23006,Alive,TUMOR FREE,1270,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1270,0,1270,0,1270,0,1270,
TCGA-BH-A0C1,BRCA,61,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22377,Dead,WITH TUMOR,NA,1411,[Not Available],Distant Metastasis,Bone,NA,1123,[Not Available],Negative,NA,1,1411,1,1411,1,1123,1,1123,
TCGA-BH-A0C3,BRCA,47,FEMALE,WHITE,Stage I,[Not Applicable],Mixed Histology (please specify),[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17221,Alive,WITH TUMOR,2709,NA,[Not Available],Distant Metastasis,Bone,NA,2674,[Not Available],Negative,NA,0,2709,0,2709,1,2674,1,2674,
TCGA-BH-A0C7,BRCA,48,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Peri (6-12 months since last menstrual period),-17871,Alive,TUMOR FREE,2767,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2767,0,2767,0,2767,0,2767,
TCGA-BH-A0DD,BRCA,58,MALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,[Not Available],-21386,Alive,TUMOR FREE,2486,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2486,0,2486,0,2486,0,2486,
TCGA-BH-A0DE,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22656,Alive,TUMOR FREE,2372,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2372,0,2372,0,2372,0,2372,
TCGA-BH-A0DG,BRCA,30,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11204,Alive,TUMOR FREE,2041,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2041,0,2041,0,2041,0,2041,
TCGA-BH-A0DH,BRCA,63,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23366,Alive,TUMOR FREE,1156,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1156,0,1156,0,1156,0,1156,
TCGA-BH-A0DI,BRCA,63,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23327,Alive,TUMOR FREE,912,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,912,0,912,0,912,0,912,
TCGA-BH-A0DK,BRCA,49,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18237,Alive,TUMOR FREE,423,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,423,0,423,0,423,0,423,
TCGA-BH-A0DL,BRCA,64,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23628,Alive,TUMOR FREE,2381,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2381,0,2381,0,2381,0,2381,
TCGA-BH-A0DO,BRCA,78,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28529,Alive,TUMOR FREE,1644,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1644,0,1644,0,1644,0,1644,
TCGA-BH-A0DP,BRCA,60,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22199,Alive,TUMOR FREE,476,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,476,0,476,0,476,0,476,
TCGA-BH-A0DQ,BRCA,42,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15533,Alive,TUMOR FREE,98,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,98,0,98,0,98,0,98,
TCGA-BH-A0DS,BRCA,71,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25944,Alive,TUMOR FREE,78,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,78,0,78,0,78,0,78,
TCGA-BH-A0DT,BRCA,41,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15078,Alive,TUMOR FREE,2403,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2403,0,2403,0,2403,0,2403,
TCGA-BH-A0DV,BRCA,54,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Peri (6-12 months since last menstrual period),-19781,Alive,TUMOR FREE,2064,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2064,0,2064,0,2064,0,2064,
TCGA-BH-A0DX,BRCA,62,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22833,Alive,TUMOR FREE,2156,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2156,0,2156,0,2156,0,2156,
TCGA-BH-A0DZ,BRCA,43,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15980,Alive,TUMOR FREE,495,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,495,0,495,0,495,0,495,
TCGA-BH-A0E0,BRCA,38,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14175,Alive,TUMOR FREE,134,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,134,0,134,0,134,0,134,
TCGA-BH-A0E1,BRCA,52,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Peri (6-12 months since last menstrual period),-19192,Alive,TUMOR FREE,477,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,477,0,477,0,477,0,477,
TCGA-BH-A0E2,BRCA,49,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18152,Alive,TUMOR FREE,435,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,435,0,435,0,435,0,435,
TCGA-BH-A0E6,BRCA,69,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25408,Alive,TUMOR FREE,293,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,293,0,293,0,293,0,293,
TCGA-BH-A0E7,BRCA,79,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29115,Alive,TUMOR FREE,1363,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1363,0,1363,0,1363,0,1363,
TCGA-BH-A0E9,BRCA,53,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19415,Alive,TUMOR FREE,2489,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2489,0,2489,0,2489,0,2489,
TCGA-BH-A0EA,BRCA,72,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26548,Dead,TUMOR FREE,NA,991,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,991,0,991,0,991,0,991,
TCGA-BH-A0EB,BRCA,69,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25259,Alive,TUMOR FREE,745,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,745,0,745,0,745,0,745,
TCGA-BH-A0EE,BRCA,68,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24850,Alive,TUMOR FREE,943,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,943,0,943,0,943,0,943,
TCGA-BH-A0EI,BRCA,51,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Peri (6-12 months since last menstrual period),-18741,Alive,TUMOR FREE,1926,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1926,0,1926,0,1926,0,1926,
TCGA-BH-A0GY,BRCA,67,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24493,Alive,TUMOR FREE,923,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,923,0,923,0,923,0,923,
TCGA-BH-A0GZ,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22714,Alive,TUMOR FREE,328,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,328,0,328,0,328,0,328,
TCGA-BH-A0H0,BRCA,69,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25223,Alive,TUMOR FREE,461,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,461,0,461,0,461,0,461,
TCGA-BH-A0H3,BRCA,46,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17152,Alive,TUMOR FREE,1928,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1928,0,1928,0,1928,0,1928,
TCGA-BH-A0H5,BRCA,45,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16719,Alive,TUMOR FREE,1620,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1620,0,1620,0,1620,0,1620,
TCGA-BH-A0H6,BRCA,82,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30125,Alive,TUMOR FREE,747,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,747,0,747,0,747,0,747,
TCGA-BH-A0H7,BRCA,65,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23972,Alive,TUMOR FREE,702,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,702,0,702,0,702,0,702,
TCGA-BH-A0H9,BRCA,69,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25289,Alive,TUMOR FREE,1247,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1247,0,1247,0,1247,0,1247,
TCGA-BH-A0HA,BRCA,31,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11379,Alive,TUMOR FREE,1611,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1611,0,1611,0,1611,0,1611,
TCGA-BH-A0HB,BRCA,55,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20448,Alive,TUMOR FREE,806,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,806,0,806,0,806,0,806,
TCGA-BH-A0HF,BRCA,77,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28233,Alive,TUMOR FREE,727,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,727,0,727,0,727,0,727,
TCGA-BH-A0HI,BRCA,78,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28644,Alive,TUMOR FREE,620,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,620,0,620,0,620,0,620,
TCGA-BH-A0HK,BRCA,81,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29751,Alive,TUMOR FREE,178,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,178,0,178,0,178,0,178,
TCGA-BH-A0HL,BRCA,56,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20804,Alive,TUMOR FREE,72,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,72,0,72,0,72,0,72,
TCGA-BH-A0HN,BRCA,67,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24731,Alive,TUMOR FREE,516,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,516,0,516,0,516,0,516,
TCGA-BH-A0HO,BRCA,48,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17710,Alive,TUMOR FREE,76,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,76,0,76,0,76,0,76,
TCGA-BH-A0HP,BRCA,65,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23883,Alive,TUMOR FREE,414,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,414,0,414,0,414,0,414,
TCGA-BH-A0HQ,BRCA,56,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20719,Alive,TUMOR FREE,1121,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1121,0,1121,0,1121,0,1121,
TCGA-BH-A0HU,BRCA,52,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Peri (6-12 months since last menstrual period),-19216,Alive,TUMOR FREE,392,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,392,0,392,0,392,0,392,
TCGA-BH-A0HW,BRCA,62,FEMALE,ASIAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22962,Alive,TUMOR FREE,1561,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1561,0,1561,0,1561,0,1561,
TCGA-BH-A0HX,BRCA,54,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19900,Alive,TUMOR FREE,829,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,829,0,829,0,829,0,829,
TCGA-BH-A0HY,BRCA,60,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22179,Alive,TUMOR FREE,1545,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1545,0,1545,0,1545,0,1545,
TCGA-BH-A0RX,BRCA,59,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21857,Alive,TUMOR FREE,170,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,170,0,170,0,170,0,170,
TCGA-BH-A0W3,BRCA,58,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Indeterminate (neither Pre or Postmenopausal),-21369,Alive,TUMOR FREE,728,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,728,0,728,NA,NA,0,728,
TCGA-BH-A0W4,BRCA,46,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,[Not Available],-16911,Alive,TUMOR FREE,759,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,759,0,759,NA,NA,0,759,
TCGA-BH-A0W5,BRCA,77,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,[Not Available],-28304,Alive,TUMOR FREE,1288,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1288,0,1288,0,1288,0,1288,
TCGA-BH-A0W7,BRCA,49,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,[Not Available],-17996,Alive,TUMOR FREE,1363,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1363,0,1363,0,1363,0,1363,
TCGA-BH-A0WA,BRCA,82,FEMALE,WHITE,Stage I,[Not Applicable],[Not Available],[Not Available],2008,[Not Available],-30025,Alive,TUMOR FREE,701,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,701,0,701,0,701,0,701,
TCGA-BH-A18F,BRCA,50,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-18594,Alive,TUMOR FREE,1001,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1001,0,1001,0,1001,0,1001,
TCGA-BH-A18G,BRCA,81,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29820,Alive,TUMOR FREE,149,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,149,0,149,0,149,0,149,
TCGA-BH-A18H,BRCA,63,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23065,Alive,TUMOR FREE,652,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,652,0,652,0,652,0,652,
TCGA-BH-A18I,BRCA,53,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19489,Alive,TUMOR FREE,1093,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1093,0,1093,0,1093,0,1093,
TCGA-BH-A18J,BRCA,56,FEMALE,WHITE,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2000,[Not Available],-20678,Dead,WITH TUMOR,NA,612,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,612,1,612,NA,NA,1,612,
TCGA-BH-A18K,BRCA,46,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1999,[Not Available],-16824,Dead,WITH TUMOR,NA,2763,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,2763,1,2763,NA,NA,1,2763,
TCGA-BH-A18L,BRCA,50,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,[Not Available],-18519,Dead,NA,NA,811,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,811,NA,811,0,811,0,811,
TCGA-BH-A18M,BRCA,39,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2001,[Not Available],-14532,Dead,NA,NA,2207,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,2207,NA,2207,0,2207,0,2207,
TCGA-BH-A18N,BRCA,88,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2001,[Not Available],-32404,Dead,NA,NA,1148,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,1148,NA,1148,0,1148,0,1148,
TCGA-BH-A18P,BRCA,60,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,[Not Available],-22222,Dead,WITH TUMOR,NA,921,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,921,1,921,NA,NA,1,921,
TCGA-BH-A18Q,BRCA,56,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2001,[Not Available],-20675,Dead,NA,NA,1692,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,1692,NA,1692,0,1692,0,1692,
TCGA-BH-A18R,BRCA,50,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2001,[Not Available],-18524,Dead,TUMOR FREE,NA,1142,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,1142,0,1142,0,1142,0,1142,
TCGA-BH-A18S,BRCA,79,FEMALE,WHITE,Stage I,[Not Applicable],Mucinous Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28974,Dead,TUMOR FREE,NA,2009,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,2009,0,2009,0,2009,0,2009,
TCGA-BH-A18T,BRCA,70,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25674,Dead,WITH TUMOR,NA,224,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,224,1,224,NA,NA,1,224,
TCGA-BH-A18U,BRCA,72,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26426,Dead,TUMOR FREE,NA,1563,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,1563,0,1563,0,1563,0,1563,
TCGA-BH-A18V,BRCA,48,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2001,[Not Available],-17682,Dead,NA,NA,1556,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,1556,NA,1556,0,1556,0,1556,
TCGA-BH-A1EN,BRCA,78,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1999,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28724,Dead,TUMOR FREE,NA,2127,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,2127,0,2127,0,2127,0,2127,
TCGA-BH-A1EO,BRCA,68,FEMALE,WHITE,Stage IIA,[Not Applicable],Mixed Histology (please specify),[Not Available],1999,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25136,Dead,TUMOR FREE,NA,2798,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,2798,0,2798,NA,NA,0,2798,
TCGA-BH-A1ES,BRCA,35,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1999,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13138,Dead,WITH TUMOR,NA,3462,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,3462,1,3462,NA,NA,1,3462,
TCGA-BH-A1ET,BRCA,55,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1999,[Not Available],-20425,Dead,TUMOR FREE,NA,2520,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,2520,0,2520,NA,NA,0,2520,
TCGA-BH-A1EU,BRCA,83,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1999,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30339,Dead,TUMOR FREE,NA,1286,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,1286,0,1286,NA,NA,0,1286,
TCGA-BH-A1EV,BRCA,45,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1999,[Not Available],-16504,Dead,WITH TUMOR,NA,365,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,365,1,365,NA,NA,1,365,
TCGA-BH-A1EW,BRCA,38,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1999,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14090,Dead,WITH TUMOR,NA,1694,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,1694,1,1694,NA,NA,1,1694,
TCGA-BH-A1EX,BRCA,67,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2000,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24544,Dead,WITH TUMOR,NA,1508,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,1508,1,1508,NA,NA,1,1508,
TCGA-BH-A1EY,BRCA,79,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2000,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28940,Dead,WITH TUMOR,NA,538,[Not Available],Distant Metastasis,Lung,Liver,396,[Not Available],[Not Available],NA,1,538,1,538,NA,NA,1,396,
TCGA-BH-A1F0,BRCA,80,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2000,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29335,Dead,WITH TUMOR,NA,785,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,785,1,785,NA,NA,1,785,
TCGA-BH-A1F2,BRCA,53,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1999,[Not Available],-19701,Dead,TUMOR FREE,NA,959,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,959,0,959,NA,NA,0,959,
TCGA-BH-A1F5,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2002,[Not Available],-22842,Dead,TUMOR FREE,NA,2712,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,2712,0,2712,NA,NA,0,2712,
TCGA-BH-A1F6,BRCA,51,FEMALE,WHITE,[Not Available],[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1996,[Not Available],-18691,Dead,NA,NA,2965,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,2965,NA,2965,NA,NA,0,2965,
TCGA-BH-A1F8,BRCA,90,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1999,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32871,Dead,WITH TUMOR,NA,763,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,763,1,763,NA,NA,1,763,
TCGA-BH-A1FB,BRCA,60,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2000,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21933,Dead,WITH TUMOR,NA,3669,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,3669,1,3669,NA,NA,1,3669,
TCGA-BH-A1FC,BRCA,78,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Medullary Carcinoma,[Not Available],1998,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28706,Dead,TUMOR FREE,NA,3472,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,3472,0,3472,NA,NA,0,3472,
TCGA-BH-A1FD,BRCA,68,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24940,Dead,WITH TUMOR,NA,1009,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,1009,1,1009,NA,NA,1,1009,
TCGA-BH-A1FE,BRCA,31,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998,[Not Available],-11650,Dead,WITH TUMOR,NA,2273,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,2273,1,2273,NA,NA,1,2273,
TCGA-BH-A1FG,BRCA,88,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32295,Dead,NA,NA,3736,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,3736,NA,3736,NA,NA,0,3736,
TCGA-BH-A1FH,BRCA,47,FEMALE,WHITE,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998,[Not Available],-17172,Dead,WITH TUMOR,NA,1034,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,1034,1,1034,NA,NA,1,1034,
TCGA-BH-A1FJ,BRCA,66,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998,[Not Available],-24262,Dead,NA,NA,1927,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,1927,NA,1927,NA,NA,0,1927,
TCGA-BH-A1FL,BRCA,69,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998,[Not Available],-25558,Dead,WITH TUMOR,NA,1673,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,1673,1,1673,NA,NA,1,1673,
TCGA-BH-A1FM,BRCA,44,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1998,[Not Available],-16289,Dead,NA,NA,1388,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,1388,NA,1388,NA,NA,0,1388,
TCGA-BH-A1FN,BRCA,34,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1997,[Not Available],-12525,Dead,WITH TUMOR,NA,2192,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,2192,1,2192,NA,NA,1,2192,
TCGA-BH-A1FR,BRCA,73,FEMALE,WHITE,Stage IIIB,[Not Applicable],"Other, specify",[Not Available],1997,[Not Available],-26684,Dead,WITH TUMOR,NA,1642,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,1642,1,1642,NA,NA,1,1642,
TCGA-BH-A1FU,BRCA,44,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1997,[Not Available],-16174,Dead,WITH TUMOR,NA,1688,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,1688,1,1688,NA,NA,1,1688,
TCGA-BH-A201,BRCA,64,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23423,Alive,TUMOR FREE,856,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,856,0,856,NA,NA,0,856,
TCGA-BH-A202,BRCA,60,FEMALE,WHITE,Stage II,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22052,Alive,TUMOR FREE,795,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,795,0,795,NA,NA,0,795,
TCGA-BH-A203,BRCA,78,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1996,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28609,Dead,WITH TUMOR,NA,1174,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,1174,1,1174,NA,NA,1,1174,
TCGA-BH-A204,BRCA,80,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1996,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29529,Dead,NA,NA,2534,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,2534,NA,2534,NA,NA,0,2534,
TCGA-BH-A208,BRCA,48,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1995,[Not Available],-17715,Dead,TUMOR FREE,NA,1759,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,1759,0,1759,NA,NA,0,1759,
TCGA-BH-A209,BRCA,77,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Medullary Carcinoma,[Not Available],1996,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28403,Dead,TUMOR FREE,NA,3959,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,3959,0,3959,NA,NA,0,3959,
TCGA-BH-A28O,BRCA,50,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,[Not Available],-18501,Alive,TUMOR FREE,1120,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1120,0,1120,0,1120,0,1120,
TCGA-BH-A28Q,BRCA,46,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16882,Alive,TUMOR FREE,1119,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,1119,0,1119,NA,NA,0,1119,
TCGA-BH-A2L8,BRCA,45,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16658,Alive,TUMOR FREE,612,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,612,0,612,0,612,0,612,
TCGA-BH-A42T,BRCA,75,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27731,Dead,TUMOR FREE,NA,320,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,320,0,320,0,320,0,320,
TCGA-BH-A42U,BRCA,80,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29330,Alive,TUMOR FREE,3364,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3364,0,3364,0,3364,0,3364,
TCGA-BH-A42V,BRCA,41,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15158,Alive,TUMOR FREE,635,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,635,0,635,0,635,0,635,
TCGA-BH-A5IZ,BRCA,51,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18927,Alive,TUMOR FREE,567,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,567,0,567,0,567,0,567,
TCGA-BH-A5J0,BRCA,63,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23072,Alive,TUMOR FREE,715,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,715,0,715,0,715,0,715,
TCGA-BH-A6R8,BRCA,46,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,[Unknown],-16829,Alive,TUMOR FREE,293,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,293,0,293,0,293,0,293,
TCGA-BH-A6R9,BRCA,61,FEMALE,WHITE,Stage IIA,[Not Applicable],Metaplastic Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22325,Alive,TUMOR FREE,160,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,160,0,160,0,160,0,160,
TCGA-BH-A8FY,BRCA,87,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31932,Dead,TUMOR FREE,NA,295,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,295,0,295,0,295,0,295,
TCGA-BH-A8FZ,BRCA,58,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21343,Alive,TUMOR FREE,574,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,574,0,574,0,574,0,574,
TCGA-BH-A8G0,BRCA,54,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Peri (6-12 months since last menstrual period),-19975,Alive,TUMOR FREE,662,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,662,0,662,0,662,0,662,
TCGA-BH-AB28,BRCA,53,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013,[Unknown],-19570,Alive,TUMOR FREE,287,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,287,0,287,0,287,0,287,
TCGA-C8-A12K,BRCA,80,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29463,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,0,0,0,0,0,0,0,
TCGA-C8-A12L,BRCA,67,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24710,Alive,TUMOR FREE,363,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,363,0,363,0,363,0,363,
TCGA-C8-A12M,BRCA,70,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25811,Alive,TUMOR FREE,358,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,358,0,358,0,358,0,358,
TCGA-C8-A12N,BRCA,58,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21428,Alive,TUMOR FREE,358,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,358,0,358,0,358,0,358,
TCGA-C8-A12O,BRCA,50,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18506,Alive,TUMOR FREE,385,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,385,0,385,0,385,0,385,
TCGA-C8-A12P,BRCA,55,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20332,Alive,TUMOR FREE,358,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,358,0,358,0,358,0,358,
TCGA-C8-A12Q,BRCA,78,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28733,Dead,WITH TUMOR,NA,385,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,385,1,385,NA,NA,1,385,
TCGA-C8-A12T,BRCA,43,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,0,0,0,0,0,0,0,
TCGA-C8-A12U,BRCA,46,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17045,Alive,TUMOR FREE,385,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,385,0,385,0,385,0,385,
TCGA-C8-A12V,BRCA,55,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20346,Alive,TUMOR FREE,385,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,385,0,385,NA,NA,0,385,
TCGA-C8-A12W,BRCA,49,FEMALE,ASIAN,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18140,Alive,TUMOR FREE,385,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,385,0,385,0,385,0,385,
TCGA-C8-A12X,BRCA,62,FEMALE,ASIAN,Stage IIB,[Not Applicable],Mucinous Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22889,Alive,TUMOR FREE,385,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,385,0,385,0,385,0,385,
TCGA-C8-A12Y,BRCA,44,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Alive,TUMOR FREE,1476,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1476,0,1476,0,1476,0,1476,
TCGA-C8-A12Z,BRCA,45,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-16508,Alive,TUMOR FREE,382,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,382,0,382,0,382,0,382,
TCGA-C8-A130,BRCA,52,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-19117,Alive,TUMOR FREE,370,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,370,0,370,0,370,0,370,
TCGA-C8-A131,BRCA,82,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29966,Alive,TUMOR FREE,411,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,411,0,411,0,411,0,411,
TCGA-C8-A132,BRCA,56,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20471,Alive,TUMOR FREE,383,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,383,0,383,0,383,0,383,
TCGA-C8-A133,BRCA,65,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Other, specify",[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23922,Alive,TUMOR FREE,0,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,0,0,0,0,0,0,0,
TCGA-C8-A134,BRCA,52,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-19010,Alive,TUMOR FREE,383,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,383,0,383,0,383,0,383,
TCGA-C8-A135,BRCA,64,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23667,Alive,TUMOR FREE,393,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,393,0,393,0,393,0,393,
TCGA-C8-A137,BRCA,34,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12729,Alive,WITH TUMOR,379,NA,[Not Available],Locoregional Recurrence,NA,NA,136,[Not Available],Negative,NA,0,379,0,379,1,136,1,136,
TCGA-C8-A138,BRCA,54,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20053,Alive,TUMOR FREE,380,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,380,0,380,0,380,0,380,
TCGA-C8-A1HE,BRCA,59,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,TUMOR FREE,375,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,375,0,375,0,375,0,375,
TCGA-C8-A1HF,BRCA,48,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Alive,TUMOR FREE,332,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,332,0,332,0,332,0,332,
TCGA-C8-A1HG,BRCA,50,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Alive,TUMOR FREE,345,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,345,0,345,0,345,0,345,
TCGA-C8-A1HI,BRCA,40,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Alive,TUMOR FREE,343,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,343,0,343,0,343,0,343,
TCGA-C8-A1HJ,BRCA,53,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-19629,Alive,TUMOR FREE,5,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,5,0,5,0,5,0,5,
TCGA-C8-A1HK,BRCA,53,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),NA,Alive,TUMOR FREE,366,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,366,0,366,0,366,0,366,
TCGA-C8-A1HL,BRCA,38,FEMALE,ASIAN,Stage IIIA,[Not Applicable],"Other, specify",[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Alive,TUMOR FREE,317,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,317,0,317,0,317,0,317,
TCGA-C8-A1HM,BRCA,74,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27063,Alive,TUMOR FREE,375,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,375,0,375,0,375,0,375,
TCGA-C8-A1HN,BRCA,56,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20712,Alive,TUMOR FREE,394,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,394,0,394,0,394,0,394,
TCGA-C8-A1HO,BRCA,34,FEMALE,ASIAN,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12715,Alive,TUMOR FREE,375,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,375,0,375,0,375,0,375,
TCGA-C8-A26V,BRCA,47,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-17468,Alive,TUMOR FREE,616,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,616,0,616,0,616,0,616,
TCGA-C8-A26W,BRCA,58,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21391,Alive,TUMOR FREE,381,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,381,0,381,0,381,0,381,
TCGA-C8-A26X,BRCA,58,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21463,Alive,TUMOR FREE,376,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,376,0,376,0,376,0,376,
TCGA-C8-A26Y,BRCA,90,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872,Alive,TUMOR FREE,394,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,394,0,394,0,394,0,394,
TCGA-C8-A26Z,BRCA,59,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,TUMOR FREE,470,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,470,0,470,0,470,0,470,
TCGA-C8-A273,BRCA,29,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NA,Alive,TUMOR FREE,513,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,513,0,513,0,513,0,513,
TCGA-C8-A274,BRCA,63,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23337,Alive,TUMOR FREE,508,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,508,0,508,0,508,0,508,
TCGA-C8-A275,BRCA,56,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20774,Alive,TUMOR FREE,1,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1,0,1,0,1,0,1,
TCGA-C8-A278,BRCA,61,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22598,Alive,TUMOR FREE,297,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,297,0,297,0,297,0,297,
TCGA-C8-A27A,BRCA,48,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-17779,Alive,TUMOR FREE,747,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,747,0,747,0,747,0,747,
TCGA-C8-A27B,BRCA,48,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Peri (6-12 months since last menstrual period),-17763,Alive,TUMOR FREE,439,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,439,0,439,0,439,0,439,
TCGA-C8-A3M7,BRCA,60,FEMALE,ASIAN,Stage IIIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22096,Dead,WITH TUMOR,NA,1034,[Not Available],Locoregional Recurrence,NA,NA,1034,[Not Available],Negative,NA,1,1034,1,1034,1,1034,1,1034,
TCGA-C8-A3M8,BRCA,68,FEMALE,ASIAN,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24877,Alive,TUMOR FREE,394,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,394,0,394,0,394,0,394,
TCGA-C8-A8HP,BRCA,59,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Metaplastic Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21613,Alive,TUMOR FREE,396,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,396,0,396,0,396,0,396,
TCGA-C8-A8HQ,BRCA,53,FEMALE,ASIAN,Stage IIB,[Not Applicable],Mucinous Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19432,Alive,TUMOR FREE,380,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,380,0,380,0,380,0,380,
TCGA-C8-A8HR,BRCA,49,FEMALE,ASIAN,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013,Peri (6-12 months since last menstrual period),-17921,Alive,TUMOR FREE,408,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,408,0,408,0,408,0,408,
TCGA-C8-A9FZ,BRCA,49,FEMALE,WHITE,Stage IIB,[Not Applicable],Mixed Histology (please specify),[Not Available],2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18038,Alive,TUMOR FREE,592,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,592,0,592,0,592,0,592,
TCGA-D8-A13Y,BRCA,52,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19028,Alive,TUMOR FREE,1728,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1728,0,1728,0,1728,0,1728,
TCGA-D8-A13Z,BRCA,51,FEMALE,WHITE,[Not Available],[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18942,Alive,TUMOR FREE,635,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,635,0,635,0,635,0,635,
TCGA-D8-A140,BRCA,62,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22900,Alive,TUMOR FREE,403,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,403,0,403,0,403,0,403,
TCGA-D8-A141,BRCA,40,FEMALE,WHITE,[Not Available],[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Indeterminate (neither Pre or Postmenopausal),-14626,Alive,TUMOR FREE,626,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,626,0,626,0,626,0,626,
TCGA-D8-A142,BRCA,74,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27313,Alive,TUMOR FREE,425,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,425,0,425,0,425,0,425,
TCGA-D8-A143,BRCA,51,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18984,Alive,TUMOR FREE,431,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,431,0,431,0,431,0,431,
TCGA-D8-A145,BRCA,80,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29280,Alive,TUMOR FREE,410,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,410,0,410,0,410,0,410,
TCGA-D8-A146,BRCA,57,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20861,Alive,TUMOR FREE,643,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,643,0,643,0,643,0,643,
TCGA-D8-A147,BRCA,45,FEMALE,WHITE,[Not Available],[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Indeterminate (neither Pre or Postmenopausal),-16736,Alive,TUMOR FREE,584,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,584,0,584,0,584,0,584,
TCGA-D8-A1J8,BRCA,77,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28444,Alive,TUMOR FREE,431,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,431,0,431,0,431,0,431,
TCGA-D8-A1J9,BRCA,48,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17879,Alive,TUMOR FREE,532,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,532,0,532,0,532,0,532,
TCGA-D8-A1JA,BRCA,60,FEMALE,WHITE,[Not Available],[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21918,Alive,WITH TUMOR,502,NA,[Not Available],Locoregional Disease,NA,NA,431,[Not Available],Negative,NA,0,502,0,502,1,431,1,431,
TCGA-D8-A1JB,BRCA,54,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19822,Alive,TUMOR FREE,1688,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1688,0,1688,0,1688,0,1688,
TCGA-D8-A1JC,BRCA,59,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21898,Alive,TUMOR FREE,480,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,480,0,480,0,480,0,480,
TCGA-D8-A1JD,BRCA,41,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15166,Alive,TUMOR FREE,552,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,552,0,552,0,552,0,552,
TCGA-D8-A1JE,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22683,Alive,TUMOR FREE,575,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,575,0,575,0,575,0,575,
TCGA-D8-A1JF,BRCA,79,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29199,Alive,TUMOR FREE,366,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,366,0,366,0,366,0,366,
TCGA-D8-A1JG,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22878,Alive,TUMOR FREE,1612,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1612,0,1612,0,1612,0,1612,
TCGA-D8-A1JH,BRCA,56,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20497,Alive,TUMOR FREE,426,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,426,0,426,0,426,0,426,
TCGA-D8-A1JI,BRCA,54,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20072,Alive,TUMOR FREE,577,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,577,0,577,0,577,0,577,
TCGA-D8-A1JJ,BRCA,54,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19966,Alive,TUMOR FREE,611,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,611,0,611,0,611,0,611,
TCGA-D8-A1JK,BRCA,90,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872,Alive,TUMOR FREE,612,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,612,0,612,0,612,0,612,
TCGA-D8-A1JL,BRCA,72,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26484,Alive,TUMOR FREE,611,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,611,0,611,0,611,0,611,
TCGA-D8-A1JM,BRCA,59,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21602,Alive,TUMOR FREE,590,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,590,0,590,0,590,0,590,
TCGA-D8-A1JN,BRCA,80,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29331,Alive,TUMOR FREE,620,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,620,0,620,0,620,0,620,
TCGA-D8-A1JP,BRCA,73,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26862,Alive,TUMOR FREE,639,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,639,0,639,0,639,0,639,
TCGA-D8-A1JS,BRCA,77,FEMALE,WHITE,Stage IA,[Not Applicable],"Other, specify",[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28178,Alive,TUMOR FREE,371,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,371,0,371,0,371,0,371,
TCGA-D8-A1JT,BRCA,70,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25677,Alive,TUMOR FREE,405,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,405,0,405,0,405,0,405,
TCGA-D8-A1JU,BRCA,51,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18733,Alive,TUMOR FREE,447,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,447,0,447,0,447,0,447,
TCGA-D8-A1X5,BRCA,81,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29734,Alive,TUMOR FREE,565,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,565,0,565,0,565,0,565,
TCGA-D8-A1X6,BRCA,80,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29256,Alive,TUMOR FREE,541,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,541,0,541,0,541,0,541,
TCGA-D8-A1X7,BRCA,40,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14858,Alive,TUMOR FREE,509,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,509,0,509,0,509,0,509,
TCGA-D8-A1X8,BRCA,62,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22995,Alive,TUMOR FREE,783,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,783,0,783,0,783,0,783,
TCGA-D8-A1X9,BRCA,66,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24417,Alive,TUMOR FREE,727,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,727,0,727,NA,NA,0,727,
TCGA-D8-A1XA,BRCA,64,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23387,Alive,TUMOR FREE,839,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,839,0,839,0,839,0,839,
TCGA-D8-A1XB,BRCA,62,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22976,Alive,TUMOR FREE,552,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,552,0,552,0,552,0,552,
TCGA-D8-A1XC,BRCA,85,FEMALE,WHITE,Stage IIIB,[Not Applicable],Mucinous Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31220,Dead,WITH TUMOR,NA,377,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,377,1,377,NA,NA,1,377,
TCGA-D8-A1XD,BRCA,36,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13510,Alive,TUMOR FREE,522,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,522,0,522,0,522,0,522,
TCGA-D8-A1XF,BRCA,45,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16787,Alive,TUMOR FREE,463,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,463,0,463,NA,NA,0,463,
TCGA-D8-A1XG,BRCA,86,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31748,Alive,TUMOR FREE,448,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,448,0,448,0,448,0,448,
TCGA-D8-A1XJ,BRCA,76,FEMALE,WHITE,Stage IIIA,[Not Applicable],"Other, specify",[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27967,Alive,TUMOR FREE,664,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,664,0,664,0,664,0,664,
TCGA-D8-A1XK,BRCA,55,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20092,Alive,TUMOR FREE,441,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,441,0,441,0,441,0,441,
TCGA-D8-A1XL,BRCA,34,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12668,Alive,TUMOR FREE,606,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,606,0,606,0,606,0,606,
TCGA-D8-A1XM,BRCA,57,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21056,Alive,TUMOR FREE,538,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,538,0,538,0,538,0,538,
TCGA-D8-A1XO,BRCA,56,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20606,Alive,TUMOR FREE,1682,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1682,0,1682,0,1682,0,1682,
TCGA-D8-A1XQ,BRCA,69,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25345,Alive,TUMOR FREE,499,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,499,0,499,0,499,0,499,
TCGA-D8-A1XR,BRCA,56,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20488,Alive,TUMOR FREE,482,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,482,0,482,0,482,0,482,
TCGA-D8-A1XS,BRCA,48,MALE,WHITE,Stage IIIC,[Not Applicable],"Other, specify",[Not Available],2010,[Not Available],-17708,Alive,TUMOR FREE,496,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,496,0,496,0,496,0,496,
TCGA-D8-A1XT,BRCA,61,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22448,Alive,TUMOR FREE,506,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,506,0,506,0,506,0,506,
TCGA-D8-A1XU,BRCA,56,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20715,Alive,TUMOR FREE,395,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,395,0,395,0,395,0,395,
TCGA-D8-A1XV,BRCA,84,FEMALE,WHITE,Stage IIA,[Not Applicable],Mucinous Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30830,Alive,TUMOR FREE,461,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,461,0,461,0,461,0,461,
TCGA-D8-A1XW,BRCA,53,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19478,Alive,TUMOR FREE,1309,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1309,0,1309,0,1309,0,1309,
TCGA-D8-A1XY,BRCA,74,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27106,Alive,TUMOR FREE,503,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,503,0,503,NA,NA,0,503,
TCGA-D8-A1XZ,BRCA,81,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29916,Alive,TUMOR FREE,466,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,466,0,466,0,466,0,466,
TCGA-D8-A1Y0,BRCA,65,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24083,Alive,TUMOR FREE,472,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,472,0,472,NA,NA,0,472,
TCGA-D8-A1Y1,BRCA,80,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29474,Dead,WITH TUMOR,NA,302,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,302,1,302,NA,NA,1,302,
TCGA-D8-A1Y2,BRCA,71,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26021,Alive,TUMOR FREE,433,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,433,0,433,0,433,0,433,
TCGA-D8-A1Y3,BRCA,61,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22317,Alive,TUMOR FREE,430,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,430,0,430,0,430,0,430,
TCGA-D8-A27E,BRCA,66,FEMALE,WHITE,Stage IA,[Not Applicable],"Other, specify",[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24315,Alive,TUMOR FREE,530,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,530,0,530,0,530,0,530,
TCGA-D8-A27F,BRCA,40,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14731,Alive,TUMOR FREE,488,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,488,0,488,0,488,0,488,
TCGA-D8-A27G,BRCA,75,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27521,Alive,TUMOR FREE,409,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,409,0,409,0,409,0,409,
TCGA-D8-A27H,BRCA,72,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26588,Alive,TUMOR FREE,397,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,397,0,397,0,397,0,397,
TCGA-D8-A27I,BRCA,58,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21327,Alive,TUMOR FREE,439,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,439,0,439,0,439,0,439,
TCGA-D8-A27K,BRCA,47,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17426,Alive,TUMOR FREE,1461,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1461,0,1461,0,1461,0,1461,
TCGA-D8-A27L,BRCA,49,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18025,Alive,TUMOR FREE,499,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,499,0,499,0,499,0,499,
TCGA-D8-A27M,BRCA,59,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21910,Alive,TUMOR FREE,410,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,410,0,410,0,410,0,410,
TCGA-D8-A27N,BRCA,36,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13243,Alive,TUMOR FREE,519,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,519,0,519,0,519,0,519,
TCGA-D8-A27P,BRCA,64,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23576,Alive,TUMOR FREE,49,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,49,0,49,0,49,0,49,
TCGA-D8-A27R,BRCA,41,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-15122,Alive,TUMOR FREE,307,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,307,0,307,0,307,0,307,
TCGA-D8-A27T,BRCA,53,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19591,Alive,TUMOR FREE,398,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,398,0,398,0,398,0,398,
TCGA-D8-A27V,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22958,Alive,TUMOR FREE,381,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,381,0,381,0,381,0,381,
TCGA-D8-A27W,BRCA,55,FEMALE,WHITE,Stage IIIB,[Not Applicable],Mucinous Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20173,Alive,TUMOR FREE,373,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,373,0,373,0,373,0,373,
TCGA-D8-A3Z5,BRCA,54,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19846,Alive,TUMOR FREE,1015,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1015,0,1015,0,1015,0,1015,
TCGA-D8-A3Z6,BRCA,56,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20629,Alive,TUMOR FREE,563,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,563,0,563,0,563,0,563,
TCGA-D8-A4Z1,BRCA,68,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25097,Alive,TUMOR FREE,659,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,659,0,659,0,659,0,659,
TCGA-D8-A73U,BRCA,88,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32208,Alive,WITH TUMOR,492,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,492,0,492,0,492,0,492,
TCGA-D8-A73W,BRCA,79,FEMALE,WHITE,Stage IIIA,[Not Applicable],Mucinous Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29125,Dead,WITH TUMOR,NA,385,[Not Available],Distant Metastasis,Lung,NA,21,[Not Available],Negative,NA,1,385,1,385,1,21,1,21,
TCGA-D8-A73X,BRCA,53,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19607,Alive,TUMOR FREE,767,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,767,0,767,0,767,0,767,
TCGA-E2-A105,BRCA,79,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28855,Alive,TUMOR FREE,1308,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1308,0,1308,0,1308,0,1308,
TCGA-E2-A106,BRCA,34,FEMALE,ASIAN,Stage IB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12528,Alive,TUMOR FREE,2541,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2541,0,2541,0,2541,0,2541,
TCGA-E2-A107,BRCA,54,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20065,Alive,TUMOR FREE,1047,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1047,0,1047,0,1047,0,1047,
TCGA-E2-A108,BRCA,64,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23530,Alive,WITH TUMOR,837,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,837,0,837,0,837,0,837,
TCGA-E2-A109,BRCA,64,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23521,Alive,TUMOR FREE,1417,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1417,0,1417,0,1417,0,1417,
TCGA-E2-A10A,BRCA,41,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15085,Alive,WITH TUMOR,1229,NA,[Not Available],Distant Metastasis,Bone,NA,75,[Not Available],Negative,NA,0,1229,0,1229,1,75,1,75,
TCGA-E2-A10B,BRCA,67,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24577,Alive,TUMOR FREE,1141,NA,[Not Available],New Primary Tumor,Lung,NA,195,[Not Available],Close,NA,0,1141,0,1141,NA,NA,1,195,
TCGA-E2-A10C,BRCA,54,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19849,Alive,TUMOR FREE,1220,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1220,0,1220,0,1220,0,1220,
TCGA-E2-A10E,BRCA,64,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23684,Alive,TUMOR FREE,865,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,865,0,865,0,865,0,865,
TCGA-E2-A10F,BRCA,47,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17257,Alive,TUMOR FREE,878,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,878,0,878,0,878,0,878,
TCGA-E2-A14N,BRCA,37,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13743,Alive,TUMOR FREE,1434,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1434,0,1434,0,1434,0,1434,
TCGA-E2-A14O,BRCA,76,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27837,Alive,TUMOR FREE,1359,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1359,0,1359,0,1359,0,1359,
TCGA-E2-A14P,BRCA,79,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28923,Alive,TUMOR FREE,1246,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1246,0,1246,0,1246,0,1246,
TCGA-E2-A14Q,BRCA,50,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18507,Alive,TUMOR FREE,1163,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1163,0,1163,0,1163,0,1163,
TCGA-E2-A14R,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22686,Alive,TUMOR FREE,1174,NA,[Not Available],New Primary Tumor,"Other, specify",Endometrial,971,[Not Available],Negative,NA,0,1174,0,1174,0,1174,1,971,
TCGA-E2-A14S,BRCA,65,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23878,Alive,TUMOR FREE,1009,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1009,0,1009,0,1009,0,1009,
TCGA-E2-A14T,BRCA,52,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19237,Alive,TUMOR FREE,2311,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2311,0,2311,0,2311,0,2311,
TCGA-E2-A14U,BRCA,74,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27389,Alive,TUMOR FREE,1318,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1318,0,1318,0,1318,0,1318,
TCGA-E2-A14V,BRCA,53,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19643,Alive,TUMOR FREE,1042,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1042,0,1042,0,1042,0,1042,
TCGA-E2-A14W,BRCA,78,MALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,[Not Available],-28664,Alive,TUMOR FREE,974,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,974,0,974,0,974,0,974,
TCGA-E2-A14X,BRCA,55,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20105,Alive,TUMOR FREE,972,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,972,0,972,0,972,0,972,
TCGA-E2-A14Y,BRCA,35,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13004,Alive,TUMOR FREE,2109,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2109,0,2109,0,2109,0,2109,
TCGA-E2-A14Z,BRCA,64,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23682,Dead,WITH TUMOR,NA,563,[Not Available],Distant Metastasis,Bone,NA,188,[Not Available],Negative,NA,1,563,1,563,1,188,1,188,
TCGA-E2-A150,BRCA,48,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17580,Alive,TUMOR FREE,1935,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1935,0,1935,0,1935,0,1935,
TCGA-E2-A152,BRCA,56,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20705,Alive,TUMOR FREE,2128,NA,[Not Available],Distant Metastasis,Liver,NA,54,[Not Available],Negative,NA,0,2128,0,2128,1,54,1,54,
TCGA-E2-A153,BRCA,51,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18875,Alive,TUMOR FREE,707,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,707,0,707,0,707,0,707,
TCGA-E2-A154,BRCA,68,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24999,Alive,TUMOR FREE,591,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,591,0,591,0,591,0,591,
TCGA-E2-A155,BRCA,58,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21348,Alive,TUMOR FREE,640,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,640,0,640,0,640,0,640,
TCGA-E2-A156,BRCA,61,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22422,Alive,TUMOR FREE,726,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,726,0,726,0,726,0,726,
TCGA-E2-A158,BRCA,43,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15903,Alive,TUMOR FREE,450,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,450,0,450,0,450,0,450,
TCGA-E2-A159,BRCA,50,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18621,Alive,TUMOR FREE,762,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,762,0,762,0,762,0,762,
TCGA-E2-A15A,BRCA,45,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16750,Alive,TUMOR FREE,710,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,710,0,710,0,710,0,710,
TCGA-E2-A15C,BRCA,61,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22583,Alive,TUMOR FREE,694,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,694,0,694,0,694,0,694,
TCGA-E2-A15D,BRCA,47,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17224,Alive,TUMOR FREE,526,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,526,0,526,0,526,0,526,
TCGA-E2-A15E,BRCA,40,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14894,Alive,TUMOR FREE,630,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,630,0,630,0,630,0,630,
TCGA-E2-A15F,BRCA,64,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23660,Alive,TUMOR FREE,658,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,658,0,658,0,658,0,658,
TCGA-E2-A15G,BRCA,76,FEMALE,WHITE,Stage IIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28013,Alive,TUMOR FREE,554,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,554,0,554,0,554,0,554,
TCGA-E2-A15H,BRCA,38,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13985,Alive,TUMOR FREE,393,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,393,0,393,0,393,0,393,
TCGA-E2-A15I,BRCA,44,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16163,Alive,TUMOR FREE,1692,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1692,0,1692,0,1692,0,1692,
TCGA-E2-A15J,BRCA,51,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18771,Alive,TUMOR FREE,1640,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1640,0,1640,0,1640,0,1640,
TCGA-E2-A15K,BRCA,58,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21514,Alive,TUMOR FREE,275,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,275,0,275,0,275,0,275,
TCGA-E2-A15L,BRCA,65,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23845,Alive,TUMOR FREE,626,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,626,0,626,0,626,0,626,
TCGA-E2-A15M,BRCA,66,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24266,Dead,TUMOR FREE,NA,336,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,336,0,336,0,336,0,336,
TCGA-E2-A15O,BRCA,89,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32583,Alive,TUMOR FREE,1545,NA,[Not Available],Locoregional Recurrence,NA,NA,1210,[Not Available],Negative,NA,0,1545,0,1545,1,1210,1,1210,
TCGA-E2-A15P,BRCA,61,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22524,Alive,TUMOR FREE,595,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,595,0,595,0,595,0,595,
TCGA-E2-A15R,BRCA,64,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23570,Alive,TUMOR FREE,1732,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1732,0,1732,0,1732,0,1732,
TCGA-E2-A15S,BRCA,34,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-12671,Alive,TUMOR FREE,428,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,428,0,428,0,428,0,428,
TCGA-E2-A15T,BRCA,65,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24054,Alive,TUMOR FREE,1563,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1563,0,1563,0,1563,0,1563,
TCGA-E2-A1AZ,BRCA,63,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23230,Alive,TUMOR FREE,2329,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2329,0,2329,0,2329,0,2329,
TCGA-E2-A1B0,BRCA,50,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18346,Alive,TUMOR FREE,1631,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1631,0,1631,0,1631,0,1631,
TCGA-E2-A1B1,BRCA,45,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16603,Alive,TUMOR FREE,2653,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2653,0,2653,0,2653,0,2653,
TCGA-E2-A1B4,BRCA,74,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27241,Dead,TUMOR FREE,NA,1004,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,1004,0,1004,0,1004,0,1004,
TCGA-E2-A1B5,BRCA,46,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17039,Alive,TUMOR FREE,984,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,984,0,984,0,984,0,984,
TCGA-E2-A1B6,BRCA,44,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16370,Alive,TUMOR FREE,867,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,867,0,867,0,867,0,867,
TCGA-E2-A1BC,BRCA,63,FEMALE,[Not Available],Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23168,Alive,TUMOR FREE,501,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,501,0,501,NA,NA,0,501,
TCGA-E2-A1BD,BRCA,53,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19627,Alive,TUMOR FREE,1133,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1133,0,1133,0,1133,0,1133,
TCGA-E2-A1IE,BRCA,61,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22510,Alive,WITH TUMOR,2362,NA,[Not Available],Distant Metastasis,Liver,NA,1810,[Not Available],Negative,NA,0,2362,0,2362,1,1810,1,1810,
TCGA-E2-A1IF,BRCA,74,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27341,Alive,TUMOR FREE,1138,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1138,0,1138,0,1138,0,1138,
TCGA-E2-A1IG,BRCA,45,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16757,Alive,TUMOR FREE,2140,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2140,0,2140,0,2140,0,2140,
TCGA-E2-A1IH,BRCA,80,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29444,Alive,TUMOR FREE,1026,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1026,0,1026,0,1026,0,1026,
TCGA-E2-A1II,BRCA,51,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18788,Alive,TUMOR FREE,1025,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1025,0,1025,0,1025,0,1025,
TCGA-E2-A1IJ,BRCA,57,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20956,Alive,TUMOR FREE,865,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,865,0,865,0,865,0,865,
TCGA-E2-A1IK,BRCA,71,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26052,Alive,TUMOR FREE,1800,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1800,0,1800,0,1800,0,1800,
TCGA-E2-A1IL,BRCA,78,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28495,Alive,TUMOR FREE,118,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,118,0,118,0,118,0,118,
TCGA-E2-A1IN,BRCA,60,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22199,Alive,TUMOR FREE,675,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,675,0,675,0,675,0,675,
TCGA-E2-A1IO,BRCA,37,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13671,Alive,TUMOR FREE,1855,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1855,0,1855,0,1855,0,1855,
TCGA-E2-A1IU,BRCA,60,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22279,Alive,TUMOR FREE,337,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,337,0,337,0,337,0,337,
TCGA-E2-A1L6,BRCA,44,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16403,Alive,TUMOR FREE,1648,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1648,0,1648,0,1648,0,1648,
TCGA-E2-A1L7,BRCA,40,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14854,Alive,TUMOR FREE,1836,NA,[Not Available],New Primary Tumor,"Other, specify",left breast,1619,[Not Available],Negative,NA,0,1836,0,1836,1,1619,1,1619,
TCGA-E2-A1L8,BRCA,52,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19187,Alive,TUMOR FREE,2240,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2240,0,2240,0,2240,0,2240,
TCGA-E2-A1L9,BRCA,40,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14868,Alive,TUMOR FREE,598,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,598,0,598,0,598,0,598,
TCGA-E2-A1LA,BRCA,59,FEMALE,[Not Available],Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21773,Alive,TUMOR FREE,748,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,748,0,748,0,748,0,748,
TCGA-E2-A1LB,BRCA,41,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15283,Alive,TUMOR FREE,2306,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2306,0,2306,0,2306,0,2306,
TCGA-E2-A1LE,BRCA,71,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26239,Dead,WITH TUMOR,NA,879,[Not Available],Distant Metastasis,Lung,NA,361,[Not Available],Negative,NA,1,879,1,879,1,361,1,361,
TCGA-E2-A1LG,BRCA,50,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Peri (6-12 months since last menstrual period),-18492,Alive,TUMOR FREE,1523,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1523,0,1523,0,1523,0,1523,
TCGA-E2-A1LH,BRCA,59,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21628,Alive,TUMOR FREE,3247,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3247,0,3247,0,3247,0,3247,
TCGA-E2-A1LI,BRCA,57,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21064,Alive,TUMOR FREE,3121,NA,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,0,3121,0,3121,NA,NA,0,3121,
TCGA-E2-A1LK,BRCA,84,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30757,Dead,WITH TUMOR,NA,266,[Not Available],Locoregional Disease,"Other, specify",Left axilla,155,[Not Available],Negative,NA,1,266,1,266,1,155,1,155,
TCGA-E2-A1LL,BRCA,73,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27028,Alive,WITH TUMOR,1309,NA,[Not Available],Distant Metastasis,Liver,NA,1303,[Not Available],Negative,NA,0,1309,0,1309,1,1303,1,1303,
TCGA-E2-A1LS,BRCA,46,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16887,Alive,TUMOR FREE,1604,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1604,0,1604,0,1604,0,1604,
TCGA-E2-A2P5,BRCA,78,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28621,Dead,WITH TUMOR,NA,821,[Not Available],Distant Metastasis,Bone,NA,597,[Not Available],Negative,NA,1,821,1,821,1,597,1,597,
TCGA-E2-A2P6,BRCA,77,FEMALE,[Not Available],Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28411,Alive,TUMOR FREE,1051,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1051,0,1051,0,1051,0,1051,
TCGA-E2-A3DX,BRCA,43,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15969,Alive,TUMOR FREE,1325,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,1325,0,1325,NA,NA,0,1325,
TCGA-E2-A56Z,BRCA,69,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25282,Alive,TUMOR FREE,252,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,252,0,252,0,252,0,252,
TCGA-E2-A570,BRCA,47,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17456,Alive,TUMOR FREE,931,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,931,0,931,0,931,0,931,
TCGA-E2-A572,BRCA,72,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26399,Alive,TUMOR FREE,1208,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1208,0,1208,0,1208,0,1208,
TCGA-E2-A573,BRCA,48,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Peri (6-12 months since last menstrual period),-17689,Alive,TUMOR FREE,1062,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1062,0,1062,0,1062,0,1062,
TCGA-E2-A574,BRCA,44,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16195,Alive,TUMOR FREE,1179,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1179,0,1179,0,1179,0,1179,
TCGA-E2-A576,BRCA,69,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25350,Alive,TUMOR FREE,1043,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1043,0,1043,0,1043,0,1043,
TCGA-E2-A9RU,BRCA,90,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32873,Alive,TUMOR FREE,538,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,538,0,538,0,538,0,538,
TCGA-E9-A1N3,BRCA,70,FEMALE,WHITE,Stage IIIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25714,Alive,TUMOR FREE,1059,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1059,0,1059,0,1059,0,1059,
TCGA-E9-A1N4,BRCA,41,FEMALE,WHITE,Stage IIIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15055,Alive,TUMOR FREE,1000,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1000,0,1000,0,1000,0,1000,
TCGA-E9-A1N5,BRCA,45,FEMALE,WHITE,Stage IIB,[Not Applicable],Mixed Histology (please specify),[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16736,Alive,TUMOR FREE,1120,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1120,0,1120,0,1120,0,1120,
TCGA-E9-A1N6,BRCA,52,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19327,Dead,WITH TUMOR,NA,678,[Not Available],Distant Metastasis,Bone,NA,443,[Not Available],Negative,NA,1,678,1,678,1,443,1,443,
TCGA-E9-A1N8,BRCA,48,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17652,Alive,TUMOR FREE,1039,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1039,0,1039,0,1039,0,1039,
TCGA-E9-A1N9,BRCA,58,FEMALE,WHITE,Stage IIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21228,Alive,TUMOR FREE,1101,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1101,0,1101,0,1101,0,1101,
TCGA-E9-A1NA,BRCA,58,FEMALE,WHITE,Stage IIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21397,Alive,TUMOR FREE,1112,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1112,0,1112,0,1112,0,1112,
TCGA-E9-A1NC,BRCA,61,FEMALE,WHITE,Stage IIB,[Not Applicable],Mixed Histology (please specify),[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22355,Alive,TUMOR FREE,1203,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1203,0,1203,0,1203,0,1203,
TCGA-E9-A1ND,BRCA,75,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27400,Alive,TUMOR FREE,1266,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1266,0,1266,0,1266,0,1266,
TCGA-E9-A1NE,BRCA,28,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10564,Alive,TUMOR FREE,1088,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1088,0,1088,0,1088,0,1088,
TCGA-E9-A1NF,BRCA,60,FEMALE,WHITE,Stage IIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21981,Dead,WITH TUMOR,NA,1072,[Not Available],Distant Metastasis,Lung,NA,90,[Not Available],Negative,NA,1,1072,1,1072,1,90,1,90,
TCGA-E9-A1NG,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22896,Dead,TUMOR FREE,NA,786,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,786,0,786,0,786,0,786,
TCGA-E9-A1NH,BRCA,71,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26221,Alive,TUMOR FREE,576,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,576,0,576,0,576,0,576,
TCGA-E9-A1NI,BRCA,51,FEMALE,WHITE,Stage IIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18985,Alive,TUMOR FREE,300,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,300,0,300,0,300,0,300,
TCGA-E9-A1QZ,BRCA,61,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22397,Alive,TUMOR FREE,755,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,755,0,755,0,755,0,755,
TCGA-E9-A1R0,BRCA,58,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21394,Alive,TUMOR FREE,860,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,860,0,860,NA,NA,0,860,
TCGA-E9-A1R2,BRCA,51,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18936,Alive,TUMOR FREE,1063,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,1063,0,1063,NA,NA,0,1063,
TCGA-E9-A1R3,BRCA,70,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25693,Alive,TUMOR FREE,78,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,78,0,78,0,78,0,78,
TCGA-E9-A1R4,BRCA,66,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24181,Alive,TUMOR FREE,186,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,186,0,186,0,186,0,186,
TCGA-E9-A1R5,BRCA,63,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23116,Alive,TUMOR FREE,92,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,92,0,92,0,92,0,92,
TCGA-E9-A1R6,BRCA,63,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23347,Alive,TUMOR FREE,339,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,339,0,339,0,339,0,339,
TCGA-E9-A1R7,BRCA,64,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23397,Alive,TUMOR FREE,1467,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1467,0,1467,0,1467,0,1467,
TCGA-E9-A1RA,BRCA,48,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17699,Alive,TUMOR FREE,1369,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1369,0,1369,0,1369,0,1369,
TCGA-E9-A1RB,BRCA,40,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14755,Dead,TUMOR FREE,NA,976,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,976,0,976,0,976,0,976,
TCGA-E9-A1RC,BRCA,56,FEMALE,WHITE,Stage IIIC,[Not Applicable],Mixed Histology (please specify),[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20795,Alive,TUMOR FREE,1224,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1224,0,1224,0,1224,0,1224,
TCGA-E9-A1RD,BRCA,67,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24719,Alive,TUMOR FREE,34,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,34,0,34,0,34,0,34,
TCGA-E9-A1RE,BRCA,74,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27392,Alive,TUMOR FREE,1419,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1419,0,1419,0,1419,0,1419,
TCGA-E9-A1RF,BRCA,68,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25119,Alive,TUMOR FREE,200,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,200,0,200,0,200,0,200,
TCGA-E9-A1RG,BRCA,62,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22788,Alive,TUMOR FREE,647,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,647,0,647,0,647,0,647,
TCGA-E9-A1RH,BRCA,63,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23224,Alive,TUMOR FREE,1417,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1417,0,1417,0,1417,0,1417,
TCGA-E9-A1RI,BRCA,43,FEMALE,WHITE,Stage IIIA,[Not Applicable],Mixed Histology (please specify),[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15942,Alive,TUMOR FREE,1449,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1449,0,1449,0,1449,0,1449,
TCGA-E9-A226,BRCA,45,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16511,Dead,WITH TUMOR,NA,1048,[Not Available],Distant Metastasis,Bone,NA,790,[Not Available],Negative,NA,1,1048,1,1048,1,790,1,790,
TCGA-E9-A227,BRCA,42,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15602,Alive,TUMOR FREE,975,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,975,0,975,0,975,0,975,
TCGA-E9-A228,BRCA,58,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21294,Alive,TUMOR FREE,1285,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1285,0,1285,0,1285,0,1285,
TCGA-E9-A229,BRCA,37,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13817,Alive,TUMOR FREE,1148,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1148,0,1148,0,1148,0,1148,
TCGA-E9-A22A,BRCA,74,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27288,Alive,TUMOR FREE,1189,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1189,0,1189,0,1189,0,1189,
TCGA-E9-A22B,BRCA,71,FEMALE,WHITE,Stage IA,[Not Applicable],Mixed Histology (please specify),[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26278,Alive,TUMOR FREE,1167,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1167,0,1167,0,1167,0,1167,
TCGA-E9-A22D,BRCA,38,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14115,Alive,TUMOR FREE,1248,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1248,0,1248,0,1248,0,1248,
TCGA-E9-A22E,BRCA,56,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20574,Alive,TUMOR FREE,1269,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1269,0,1269,0,1269,0,1269,
TCGA-E9-A22G,BRCA,47,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17300,Alive,TUMOR FREE,1239,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1239,0,1239,0,1239,0,1239,
TCGA-E9-A22H,BRCA,42,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15504,Alive,TUMOR FREE,1232,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1232,0,1232,0,1232,0,1232,
TCGA-E9-A243,BRCA,52,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Peri (6-12 months since last menstrual period),-19035,Alive,WITH TUMOR,612,NA,[Not Available],Distant Metastasis,Bone,NA,305,[Not Available],Negative,NA,0,612,0,612,1,305,1,305,
TCGA-E9-A244,BRCA,54,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19778,Alive,TUMOR FREE,21,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,21,0,21,0,21,0,21,
TCGA-E9-A245,BRCA,47,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17363,Alive,TUMOR FREE,26,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,26,0,26,0,26,0,26,
TCGA-E9-A247,BRCA,59,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21562,Alive,TUMOR FREE,1186,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1186,0,1186,0,1186,0,1186,
TCGA-E9-A248,BRCA,51,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Peri (6-12 months since last menstrual period),-18684,Alive,TUMOR FREE,59,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,59,0,59,0,59,0,59,
TCGA-E9-A249,BRCA,45,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16689,Alive,TUMOR FREE,217,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,217,0,217,0,217,0,217,
TCGA-E9-A24A,BRCA,69,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25370,Alive,TUMOR FREE,747,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,747,0,747,0,747,0,747,
TCGA-E9-A295,BRCA,71,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25957,Alive,TUMOR FREE,375,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,375,0,375,0,375,0,375,
TCGA-E9-A2JS,BRCA,72,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26407,Dead,WITH TUMOR,NA,904,[Not Available],Distant Metastasis,Bone,Liver,524,[Not Available],Negative,NA,1,904,1,904,1,524,1,524,
TCGA-E9-A2JT,BRCA,63,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23318,Alive,TUMOR FREE,288,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,288,0,288,0,288,0,288,
TCGA-E9-A3HO,BRCA,49,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18046,Alive,TUMOR FREE,1158,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1158,0,1158,0,1158,0,1158,
TCGA-E9-A3Q9,BRCA,78,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28715,Alive,TUMOR FREE,1001,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1001,0,1001,0,1001,0,1001,
TCGA-E9-A3QA,BRCA,33,FEMALE,WHITE,Stage IIA,[Not Applicable],Medullary Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12142,Alive,TUMOR FREE,918,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,918,0,918,0,918,0,918,
TCGA-E9-A3X8,BRCA,48,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17588,Alive,TUMOR FREE,926,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,926,0,926,0,926,0,926,
TCGA-E9-A54X,BRCA,85,FEMALE,WHITE,Stage IA,[Not Applicable],Mucinous Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31173,Alive,TUMOR FREE,727,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,727,0,727,0,727,0,727,
TCGA-E9-A54Y,BRCA,63,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23057,Alive,TUMOR FREE,725,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,725,0,725,0,725,0,725,
TCGA-E9-A5FK,BRCA,60,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22199,Alive,TUMOR FREE,812,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,812,0,812,0,812,0,812,
TCGA-E9-A5FL,BRCA,65,FEMALE,WHITE,Stage IIB,[Not Applicable],Metaplastic Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24053,Alive,TUMOR FREE,24,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,24,0,24,0,24,0,24,
TCGA-E9-A5UO,BRCA,41,FEMALE,WHITE,Stage IIA,[Not Applicable],Mucinous Carcinoma,[Not Available],2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15050,Alive,TUMOR FREE,785,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,785,0,785,0,785,0,785,
TCGA-E9-A5UP,BRCA,63,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23371,Alive,TUMOR FREE,803,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,803,0,803,0,803,0,803,
TCGA-E9-A6HE,BRCA,45,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16697,Alive,TUMOR FREE,847,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,847,0,847,0,847,0,847,
TCGA-EW-A1IW,BRCA,80,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29529,Alive,TUMOR FREE,371,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,371,0,371,0,371,0,371,
TCGA-EW-A1IX,BRCA,48,FEMALE,ASIAN,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2008,Peri (6-12 months since last menstrual period),-17597,Alive,TUMOR FREE,1208,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1208,0,1208,0,1208,0,1208,
TCGA-EW-A1IY,BRCA,38,FEMALE,ASIAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14122,Alive,TUMOR FREE,258,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,258,0,258,0,258,0,258,
TCGA-EW-A1IZ,BRCA,53,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19706,Alive,TUMOR FREE,554,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,554,0,554,0,554,0,554,
TCGA-EW-A1J1,BRCA,38,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14122,Alive,TUMOR FREE,575,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,575,0,575,0,575,0,575,
TCGA-EW-A1J2,BRCA,50,FEMALE,BLACK OR AFRICAN AMERICAN,[Discrepancy],[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18558,Alive,TUMOR FREE,403,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,403,0,403,0,403,0,403,
TCGA-EW-A1J3,BRCA,61,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22332,Alive,TUMOR FREE,504,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,504,0,504,0,504,0,504,
TCGA-EW-A1J5,BRCA,59,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21559,Alive,TUMOR FREE,477,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,477,0,477,0,477,0,477,
TCGA-EW-A1J6,BRCA,70,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25830,Alive,TUMOR FREE,875,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,875,0,875,0,875,0,875,
TCGA-EW-A1OV,BRCA,56,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20764,Alive,TUMOR FREE,789,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,789,0,789,0,789,0,789,
TCGA-EW-A1OW,BRCA,58,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21465,Alive,TUMOR FREE,694,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,694,0,694,0,694,0,694,
TCGA-EW-A1OX,BRCA,43,FEMALE,WHITE,Stage IIA,[Not Applicable],Mucinous Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15837,Alive,TUMOR FREE,911,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,911,0,911,0,911,0,911,
TCGA-EW-A1OY,BRCA,63,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23266,Alive,TUMOR FREE,908,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,908,0,908,0,908,0,908,
TCGA-EW-A1OZ,BRCA,56,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20664,Alive,TUMOR FREE,1229,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1229,0,1229,0,1229,0,1229,
TCGA-EW-A1P0,BRCA,55,FEMALE,WHITE,Stage IIB,[Not Applicable],"Other, specify",[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20107,Alive,TUMOR FREE,1251,NA,[Not Available],Distant Metastasis,"Other, specify",mediastinal lymph node,1094,[Not Available],Negative,NA,0,1251,0,1251,1,1094,1,1094,
TCGA-EW-A1P1,BRCA,68,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24923,Alive,TUMOR FREE,1210,NA,[Not Available],Distant Metastasis,Lung,NA,1014,[Not Available],Negative,NA,0,1210,0,1210,1,1014,1,1014,
TCGA-EW-A1P3,BRCA,48,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17637,Alive,TUMOR FREE,1611,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1611,0,1611,0,1611,0,1611,
TCGA-EW-A1P4,BRCA,43,FEMALE,WHITE,Stage IIA,[Not Applicable],Medullary Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15989,Alive,TUMOR FREE,907,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,907,0,907,0,907,0,907,
TCGA-EW-A1P5,BRCA,77,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28177,Alive,TUMOR FREE,703,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,703,0,703,0,703,0,703,
TCGA-EW-A1P6,BRCA,64,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23485,Alive,TUMOR FREE,562,NA,[Not Available],NA,NA,NA,NA,[Not Available],Close,NA,0,562,0,562,NA,NA,0,562,
TCGA-EW-A1P7,BRCA,59,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21750,Alive,WITH TUMOR,915,NA,[Not Available],Distant Metastasis,"Other, specify",mediastinal lymph nodes,729,[Not Available],Negative,NA,0,915,0,915,1,729,1,729,
TCGA-EW-A1P8,BRCA,58,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21501,Dead,WITH TUMOR,NA,239,[Not Available],Distant Metastasis,Lung,NA,207,[Not Available],Negative,NA,1,239,1,239,1,207,1,207,
TCGA-EW-A1PA,BRCA,59,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21837,Alive,TUMOR FREE,575,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,575,0,575,0,575,0,575,
TCGA-EW-A1PB,BRCA,70,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25770,Alive,TUMOR FREE,608,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,608,0,608,0,608,0,608,
TCGA-EW-A1PC,BRCA,66,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24434,Alive,TUMOR FREE,187,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,187,0,187,0,187,0,187,
TCGA-EW-A1PD,BRCA,61,MALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,[Not Available],-22536,Alive,TUMOR FREE,424,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,424,0,424,0,424,0,424,
TCGA-EW-A1PE,BRCA,56,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20694,Alive,TUMOR FREE,320,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,320,0,320,0,320,0,320,
TCGA-EW-A1PF,BRCA,50,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18384,Alive,TUMOR FREE,439,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,439,0,439,0,439,0,439,
TCGA-EW-A1PG,BRCA,53,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19464,Alive,TUMOR FREE,1051,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1051,0,1051,0,1051,0,1051,
TCGA-EW-A1PH,BRCA,52,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19073,Alive,TUMOR FREE,607,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,607,0,607,0,607,0,607,
TCGA-EW-A2FR,BRCA,59,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21628,Alive,TUMOR FREE,1673,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1673,0,1673,0,1673,0,1673,
TCGA-EW-A2FS,BRCA,41,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15302,Alive,TUMOR FREE,1604,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1604,0,1604,0,1604,0,1604,
TCGA-EW-A2FV,BRCA,39,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Other, specify",[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14316,Alive,TUMOR FREE,788,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,788,0,788,0,788,0,788,
TCGA-EW-A2FW,BRCA,52,FEMALE,WHITE,Stage IIA,[Not Applicable],"Other, specify",[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19085,Alive,TUMOR FREE,672,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,672,0,672,0,672,0,672,
TCGA-EW-A3E8,BRCA,60,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,[Not Evaluated],-21922,Alive,TUMOR FREE,1035,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1035,0,1035,0,1035,0,1035,
TCGA-EW-A3U0,BRCA,61,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22520,Alive,TUMOR FREE,532,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,532,0,532,0,532,0,532,
TCGA-EW-A423,BRCA,75,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27627,Alive,TUMOR FREE,533,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,533,0,533,0,533,0,533,
TCGA-EW-A424,BRCA,51,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,[Not Evaluated],-18850,Alive,TUMOR FREE,715,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,715,0,715,0,715,0,715,
TCGA-EW-A6S9,BRCA,34,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,[Not Available],-12755,Alive,TUMOR FREE,463,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,463,0,463,NA,NA,0,463,
TCGA-EW-A6SA,BRCA,59,MALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,[Not Available],-21623,Alive,TUMOR FREE,510,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,510,0,510,0,510,0,510,
TCGA-EW-A6SB,BRCA,62,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,[Not Available],-22844,Alive,TUMOR FREE,760,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,760,0,760,0,760,0,760,
TCGA-EW-A6SC,BRCA,60,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,[Not Available],-21918,Alive,TUMOR FREE,952,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,952,0,952,0,952,0,952,
TCGA-EW-A6SD,BRCA,32,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,[Not Available],-12006,Alive,TUMOR FREE,1010,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1010,0,1010,0,1010,0,1010,
TCGA-GI-A2C8,BRCA,63,FEMALE,WHITE,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,[Not Available],-23103,Alive,NA,225,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,225,0,225,0,225,0,225,
TCGA-GI-A2C9,BRCA,58,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21534,Alive,TUMOR FREE,3342,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3342,0,3342,0,3342,0,3342,
TCGA-GM-A2D9,BRCA,69,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25490,Dead,WITH TUMOR,NA,1812,[Not Available],Distant Metastasis,Bone,NA,536,[Not Available],Negative,NA,1,1812,1,1812,1,536,1,536,
TCGA-GM-A2DA,BRCA,46,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],1993,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16854,Dead,WITH TUMOR,NA,6593,[Not Available],Distant Metastasis,Bone,NA,3014,[Not Available],Negative,NA,1,6593,1,6593,1,3014,1,3014,
TCGA-GM-A2DB,BRCA,62,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22883,Alive,TUMOR FREE,2406,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2406,0,2406,0,2406,0,2406,
TCGA-GM-A2DC,BRCA,57,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21122,Alive,TUMOR FREE,2535,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2535,0,2535,0,2535,0,2535,
TCGA-GM-A2DD,BRCA,53,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19415,Alive,TUMOR FREE,2282,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2282,0,2282,0,2282,0,2282,
TCGA-GM-A2DF,BRCA,53,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19614,Alive,TUMOR FREE,2155,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2155,0,2155,0,2155,0,2155,
TCGA-GM-A2DH,BRCA,58,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21344,Alive,TUMOR FREE,2193,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2193,0,2193,0,2193,0,2193,
TCGA-GM-A2DI,BRCA,52,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19030,Alive,TUMOR FREE,2590,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2590,0,2590,0,2590,0,2590,
TCGA-GM-A2DK,BRCA,58,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21198,Alive,TUMOR FREE,2645,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2645,0,2645,0,2645,0,2645,
TCGA-GM-A2DL,BRCA,50,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2003,Peri (6-12 months since last menstrual period),-18475,Alive,TUMOR FREE,3519,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3519,0,3519,0,3519,0,3519,
TCGA-GM-A2DM,BRCA,57,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21160,Alive,TUMOR FREE,3226,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3226,0,3226,0,3226,0,3226,
TCGA-GM-A2DN,BRCA,58,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21288,Alive,TUMOR FREE,3091,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3091,0,3091,0,3091,0,3091,
TCGA-GM-A2DO,BRCA,54,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19842,Alive,TUMOR FREE,2596,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2596,0,2596,0,2596,0,2596,
TCGA-GM-A3NW,BRCA,63,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23041,Alive,TUMOR FREE,3361,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3361,0,3361,0,3361,0,3361,
TCGA-GM-A3NY,BRCA,72,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26642,Alive,TUMOR FREE,1162,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1162,0,1162,0,1162,0,1162,
TCGA-GM-A3XG,BRCA,46,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16948,Alive,TUMOR FREE,1330,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1330,0,1330,0,1330,0,1330,
TCGA-GM-A3XL,BRCA,49,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18171,Alive,TUMOR FREE,2108,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2108,0,2108,0,2108,0,2108,
TCGA-GM-A3XN,BRCA,44,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16109,Alive,TUMOR FREE,2019,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2019,0,2019,0,2019,0,2019,
TCGA-GM-A4E0,BRCA,67,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24788,Alive,TUMOR FREE,2191,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2191,0,2191,0,2191,0,2191,
TCGA-GM-A5PV,BRCA,63,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23215,Alive,TUMOR FREE,412,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,412,0,412,0,412,0,412,
TCGA-GM-A5PX,BRCA,65,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23753,Alive,TUMOR FREE,551,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,551,0,551,0,551,0,551,
TCGA-HN-A2NL,BRCA,56,FEMALE,[Not Evaluated],Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20483,Alive,TUMOR FREE,79,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,79,0,79,0,79,0,79,
TCGA-HN-A2OB,BRCA,45,FEMALE,[Not Evaluated],Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16672,Dead,WITH TUMOR,NA,1900,[Not Available],Distant Metastasis,Bone,NA,1543,[Not Available],Negative,NA,1,1900,1,1900,1,1543,1,1543,
TCGA-JL-A3YW,BRCA,49,FEMALE,ASIAN,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,NA,360,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,360,0,360,0,360,0,360,
TCGA-JL-A3YX,BRCA,46,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,NA,352,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,352,0,352,0,352,0,352,
TCGA-LD-A66U,BRCA,44,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,[Not Evaluated],-16101,Alive,TUMOR FREE,646,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,646,0,646,0,646,0,646,
TCGA-LD-A74U,BRCA,79,FEMALE,WHITE,Stage IIIC,[Not Applicable],"Other, specify",[Not Available],2013,[Not Available],-28981,Alive,WITH TUMOR,402,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,402,0,402,0,402,0,402,
TCGA-LD-A7W5,BRCA,52,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19169,Alive,WITH TUMOR,216,NA,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,0,216,0,216,NA,NA,0,216,
TCGA-LD-A7W6,BRCA,54,FEMALE,WHITE,Stage IIB,[Not Applicable],"Other, specify",[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20077,Alive,TUMOR FREE,404,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,404,0,404,0,404,0,404,
TCGA-LD-A9QF,BRCA,73,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26869,Alive,TUMOR FREE,323,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,323,0,323,0,323,0,323,
TCGA-LL-A440,BRCA,61,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22497,Alive,TUMOR FREE,759,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,759,0,759,0,759,0,759,
TCGA-LL-A441,BRCA,62,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22772,Alive,TUMOR FREE,996,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,996,0,996,0,996,0,996,
TCGA-LL-A442,BRCA,56,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20495,Alive,TUMOR FREE,889,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,889,0,889,0,889,0,889,
TCGA-LL-A50Y,BRCA,84,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30934,Alive,TUMOR FREE,762,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,762,0,762,0,762,0,762,
TCGA-LL-A5YL,BRCA,64,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23395,Alive,NA,519,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,519,0,519,0,519,0,519,
TCGA-LL-A5YM,BRCA,88,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32478,Alive,WITH TUMOR,466,NA,[Not Available],Locoregional Recurrence,"Other, specify",Skin left chest wall,258,[Not Available],Negative,NA,0,466,0,466,1,258,1,258,
TCGA-LL-A5YN,BRCA,46,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16884,Alive,TUMOR FREE,447,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,447,0,447,0,447,0,447,
TCGA-LL-A5YO,BRCA,50,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18354,Alive,TUMOR FREE,440,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,440,0,440,0,440,0,440,
TCGA-LL-A5YP,BRCA,49,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18041,Alive,NA,450,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,450,0,450,0,450,0,450,
TCGA-LL-A6FP,BRCA,90,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32873,Alive,TUMOR FREE,677,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,677,0,677,0,677,0,677,
TCGA-LL-A6FQ,BRCA,77,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28375,Alive,NA,80,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,80,0,80,0,80,0,80,
TCGA-LL-A6FR,BRCA,50,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18520,Alive,TUMOR FREE,489,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,489,0,489,0,489,0,489,
TCGA-LL-A73Y,BRCA,67,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24647,Alive,TUMOR FREE,477,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,477,0,477,0,477,0,477,
TCGA-LL-A73Z,BRCA,55,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20118,Dead,WITH TUMOR,NA,227,[Not Available],Distant Metastasis,Brain,NA,192,[Not Available],Positive,NA,1,227,1,227,NA,NA,1,192,
TCGA-LL-A740,BRCA,61,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22416,Alive,TUMOR FREE,441,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,441,0,441,0,441,0,441,
TCGA-LL-A7SZ,BRCA,49,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18161,Alive,TUMOR FREE,594,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,594,0,594,0,594,0,594,
TCGA-LL-A7T0,BRCA,70,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25867,Alive,TUMOR FREE,376,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,376,0,376,0,376,0,376,
TCGA-LL-A8F5,BRCA,61,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22544,Alive,TUMOR FREE,596,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,596,0,596,0,596,0,596,
TCGA-LL-A9Q3,BRCA,69,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25477,Alive,TUMOR FREE,532,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,532,0,532,0,532,0,532,
TCGA-LQ-A4E4,BRCA,73,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26883,Alive,WITH TUMOR,849,NA,[Not Available],Distant Metastasis,Bone,NA,681,[Not Available],Positive,NA,0,849,0,849,NA,NA,1,681,
TCGA-MS-A51U,BRCA,44,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,[Not Available],-16213,Alive,TUMOR FREE,681,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,681,0,681,0,681,0,681,
TCGA-OK-A5Q2,BRCA,59,FEMALE,[Not Evaluated],Stage II,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,[Unknown],-21555,Alive,NA,64,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,64,0,64,0,64,0,64,
TCGA-OL-A5D6,BRCA,71,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26052,Dead,TUMOR FREE,NA,1104,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,1104,0,1104,0,1104,0,1104,
TCGA-OL-A5D7,BRCA,70,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25643,Alive,TUMOR FREE,1780,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1780,0,1780,0,1780,0,1780,
TCGA-OL-A5D8,BRCA,40,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14853,Alive,TUMOR FREE,973,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Unknown],NA,0,973,0,973,NA,NA,0,973,
TCGA-OL-A5DA,BRCA,61,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22411,Alive,TUMOR FREE,1783,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1783,0,1783,0,1783,0,1783,
TCGA-OL-A5RU,BRCA,63,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23108,Alive,TUMOR FREE,1219,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1219,0,1219,0,1219,0,1219,
TCGA-OL-A5RV,BRCA,43,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15820,Alive,TUMOR FREE,1062,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1062,0,1062,0,1062,0,1062,
TCGA-OL-A5RW,BRCA,40,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14638,Alive,TUMOR FREE,1106,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1106,0,1106,0,1106,0,1106,
TCGA-OL-A5RX,BRCA,51,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18942,Alive,TUMOR FREE,878,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,878,0,878,0,878,0,878,
TCGA-OL-A5RY,BRCA,52,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19216,Alive,TUMOR FREE,752,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,752,0,752,0,752,0,752,
TCGA-OL-A5RZ,BRCA,57,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21038,Alive,TUMOR FREE,679,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,679,0,679,0,679,0,679,
TCGA-OL-A5S0,BRCA,66,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24139,Alive,TUMOR FREE,620,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,620,0,620,0,620,0,620,
TCGA-OL-A66H,BRCA,NA,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,[Not Applicable],Mucinous Carcinoma,[Not Available],NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,TUMOR FREE,NA,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,NA,0,NA,0,NA,0,NA,
TCGA-OL-A66I,BRCA,36,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2008,[Not Evaluated],-13458,Alive,TUMOR FREE,714,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,714,0,714,0,714,0,714,
TCGA-OL-A66J,BRCA,80,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29345,Alive,TUMOR FREE,1996,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1996,0,1996,0,1996,0,1996,
TCGA-OL-A66K,BRCA,72,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26299,Dead,TUMOR FREE,NA,1275,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,1,1275,0,1275,0,1275,0,1275,
TCGA-OL-A66L,BRCA,71,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26186,Alive,TUMOR FREE,1301,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1301,0,1301,0,1301,0,1301,
TCGA-OL-A66N,BRCA,59,FEMALE,WHITE,Stage IIIC,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21608,Alive,TUMOR FREE,792,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,792,0,792,0,792,0,792,
TCGA-OL-A66O,BRCA,39,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14272,Alive,TUMOR FREE,528,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,528,0,528,0,528,0,528,
TCGA-OL-A66P,BRCA,75,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,[Not Available],-27489,Alive,TUMOR FREE,428,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,428,0,428,0,428,0,428,
TCGA-OL-A6VO,BRCA,43,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2012,[Unknown],-15780,Alive,TUMOR FREE,858,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,858,0,858,0,858,0,858,
TCGA-OL-A6VQ,BRCA,49,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18151,Alive,TUMOR FREE,600,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,600,0,600,0,600,0,600,
TCGA-OL-A6VR,BRCA,48,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2011,[Unknown],-17702,Alive,TUMOR FREE,1220,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1220,0,1220,0,1220,0,1220,
TCGA-OL-A97C,BRCA,67,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],"Other, specify",[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24735,Alive,TUMOR FREE,271,NA,[Not Available],Distant Metastasis,Lung,NA,275,[Not Available],[Not Available],NA,0,271,0,271,NA,NA,1,275,
TCGA-PE-A5DC,BRCA,72,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26514,Dead,TUMOR FREE,NA,1430,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,1,1430,0,1430,NA,NA,0,1430,
TCGA-PE-A5DD,BRCA,64,FEMALE,ASIAN,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23686,Alive,TUMOR FREE,1953,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1953,0,1953,0,1953,0,1953,
TCGA-PE-A5DE,BRCA,41,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15216,Alive,TUMOR FREE,2645,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,2645,0,2645,NA,NA,0,2645,
TCGA-PL-A8LV,BRCA,54,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Medullary Carcinoma,[Not Available],2013,[Unknown],-19746,Alive,WITH TUMOR,-7,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,0,0,0,NA,NA,0,0,
TCGA-PL-A8LX,BRCA,35,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12840,Alive,WITH TUMOR,5,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,5,0,5,NA,NA,0,5,
TCGA-PL-A8LY,BRCA,30,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11199,Alive,WITH TUMOR,8,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,8,0,8,NA,NA,0,8,
TCGA-PL-A8LZ,BRCA,29,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10869,Alive,TUMOR FREE,302,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,302,0,302,NA,NA,0,302,
TCGA-S3-A6ZF,BRCA,64,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23650,Alive,TUMOR FREE,572,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,572,0,572,0,572,0,572,
TCGA-S3-A6ZG,BRCA,71,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Mixed Histology (please specify),[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26141,Alive,TUMOR FREE,562,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,562,0,562,0,562,0,562,
TCGA-S3-A6ZH,BRCA,29,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,[Unknown],-10832,Alive,TUMOR FREE,641,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,641,0,641,0,641,0,641,
TCGA-S3-AA0Z,BRCA,63,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23314,Alive,TUMOR FREE,629,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,629,0,629,0,629,0,629,
TCGA-S3-AA10,BRCA,65,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24075,Alive,TUMOR FREE,586,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,586,0,586,0,586,0,586,
TCGA-S3-AA11,BRCA,67,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24813,Alive,TUMOR FREE,421,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,421,0,421,0,421,0,421,
TCGA-S3-AA12,BRCA,82,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30101,Alive,TUMOR FREE,574,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,574,0,574,0,574,0,574,
TCGA-S3-AA14,BRCA,47,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17352,Alive,TUMOR FREE,529,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,529,0,529,0,529,0,529,
TCGA-S3-AA15,BRCA,51,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18659,Alive,TUMOR FREE,525,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,525,0,525,0,525,0,525,
TCGA-S3-AA17,BRCA,64,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23642,Alive,TUMOR FREE,424,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,424,0,424,0,424,0,424,
TCGA-UL-AAZ6,BRCA,73,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26999,Alive,TUMOR FREE,518,NA,[Not Available],NA,NA,NA,NA,[Not Available],[Not Available],NA,0,518,0,518,NA,NA,0,518,
TCGA-UU-A93S,BRCA,63,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23278,Dead,WITH TUMOR,NA,116,[Not Available],NA,NA,NA,NA,[Not Available],Positive,NA,1,116,1,116,NA,NA,1,116,
TCGA-V7-A7HQ,BRCA,75,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27684,Alive,TUMOR FREE,2033,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,2033,0,2033,0,2033,0,2033,
TCGA-W8-A86G,BRCA,66,FEMALE,WHITE,Stage IIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24125,Alive,TUMOR FREE,347,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,347,0,347,0,347,0,347,
TCGA-WT-AB41,BRCA,55,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Infiltrating Ductal Carcinoma,[Not Available],2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,TUMOR FREE,1611,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,1611,0,1611,0,1611,0,1611,
TCGA-WT-AB44,BRCA,77,FEMALE,WHITE,Stage IA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,TUMOR FREE,883,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,883,0,883,0,883,0,883,
TCGA-XX-A899,BRCA,46,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17022,Alive,TUMOR FREE,467,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,467,0,467,0,467,0,467,
TCGA-XX-A89A,BRCA,68,FEMALE,WHITE,Stage IIB,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25000,Alive,TUMOR FREE,488,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,488,0,488,0,488,0,488,
TCGA-Z7-A8R5,BRCA,61,FEMALE,WHITE,Stage IIIA,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22280,Alive,WITH TUMOR,3287,NA,[Not Available],Locoregional Recurrence,NA,NA,181,[Not Available],Positive,NA,0,3287,0,3287,NA,NA,1,181,
TCGA-Z7-A8R6,BRCA,46,FEMALE,WHITE,Stage I,[Not Applicable],Infiltrating Lobular Carcinoma,[Not Available],2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16955,Alive,TUMOR FREE,3256,NA,[Not Available],NA,NA,NA,NA,[Not Available],Negative,NA,0,3256,0,3256,0,3256,0,3256,